전체 연도 결과
월 4 2024
글로벌데이터 PLC
전체 연도 결과
31 12월 2023
Strong results and Adjusted EBITDA margin above 40% for first time
Growth Optimisation Plan completed ahead of schedule
New Growth Transformation Plan launched to accelerate value creation
GlobalData Plc (AIM: DATA, GlobalData, the Group), a leading data, analytics, and insights platform, today publishes its results for the year ended 31 December 2023 (FY23).
· Excellent growth in Adjusted EBITDA (+28%), with margins accelerating to 41%
· Total revenue growth of 12% and strong underlying revenue growth of 7%
· Statutory profit before tax grew by £3.1m to £41.5m (2022: £38.4m) reflecting an 8% increase on prior year
· Proposed final dividend of 3.2p increases total dividend by 28% to 4.6 pence per share
· Launch of new Growth Transformation Plan 2024-2026 and reorganisation into three focused divisions - Healthcare, Consumer, Technology
· Inflexion acquisition of 40% of Healthcare division on track to close during Q2 2024. Net cash proceeds of approximately £434m will provide flexibility for accelerated value-creating M&A across the Group
· Well positioned for sustainable organic growth, supported by value accretive M&A
GlobalData Plc의 CEO인 Mike Danson은 다음과 같이 말했습니다.
"2023 has been a year of positive operational and financial momentum for GlobalData. Over the last four years we have transformed this business, having completed our Growth Optimisation Plan, which was set to finish at the end of 2024, earlier than planned.
Investment in our One Platform has continued at pace as a wide range of corporates embed our mission critical data into their workflow. We look forward to welcoming Inflexion, who will invest to become 40% minority shareholder in our Healthcare business. This significant milestone in our evolution will unlock substantial value for our shareholders and offers us the flexibility to launch a more ambitious approach to growth, including accelerating value-creating M&A across the Group.
We enter the new financial year with the Group now re-organised across three customer-focused divisions - Healthcare, Consumer and Technology and with c.80% revenue visibility. Investing in our product and AI, sales resources and M&A are key priorities. With a clear vision and a strong team ready to execute our new Growth Transformation Plan, we look forward to the year ahead with confidence as we seek to significantly expand GlobalData's scale, speed up our growth, and sustain value creation for our stakeholders."
하이라이트
31년 2023월 XNUMX일에 종료된 연도의 재무 결과.
주요 성능 지표 | 2023 | 2022 | 성장 | 기본 성장1 |
수익 | £ 273.1m | £ 243.2m | 12% | 7% |
영업 이익 | £ 73.7m | £ 56.0m | 32% | |
영업 이익률 | 27% | 23% | +4 점 | |
조정 된 EBITDA1 | £ 110.8m | £ 86.4m | 28% | |
조정 된 EBITDA 마진1 | 41% | 36% | +5 점 | |
세전 법정 이익(PBT) | £ 41.5m | £ 38.4m | 8% | |
주당 순이익 (EPS) | 3.8p | 3.8p2 | - | |
조정 된 EPS1 | 6.8p | 6.1p2 | 11% | |
총 배당금 | 4.6p | 3.6p2 | 28% | |
인보이스 전달 수익1 | £ 135.2m | £ 133.5m | 1% | 4% |
순 은행 부채1 | £ 243.9m | £ 249.6m | -2 % |
재무 하이라이트
· Strong growth in both revenue and profit
o The full year impact of acquisitions augmented underlying revenue progression, to report overall revenue growth of 12%.
o Robust underlying revenue growth of 7% (2022: 10%) was underpinned by subscriptions which represented 79% of total revenues (2022: 81%).
o Significant Adjusted EBITDA margin expansion to 41% (2022: 36%).
· Adjusted EBITDA up 28% to £110.8m (2022: £86.4m).
· Statutory PBT grew by £3.1m to £41.5m (2022: £38.4m) an 8% increase on prior year.
· Operating cash flow grew by 18% to £101.0m (2022: £85.4m).
· Invoiced Forward Revenue grew to £135.2m (underlying growth of 4%) at 31 December 2023 (31 December 2022: £133.5m).
· Enter FY24 with c.80% visibility (contracted and renewable revenues) of budgeted revenues.
· Total dividends grew by 28% to 4.6p (2022: 3.6p 회복2).
운영 하이라이트
· Completed our Growth Optimisation Plan a year earlier than expected via four key pillars:
o Customer Obsession, World-Class Product, Sales Excellence and Operational Agility
· In December, launched our new Growth Transformation Plan 2024-2026, continuing to use the same four pillar framework
o Transformational growth initiatives set GlobalData up for future success:
§ Three customer focused divisions from FY24: Healthcare, Consumer and Technology.
§ Accelerate our investment in Artificial Intelligence capability and make Artificial Intelligence central to our strategy and operations.
§ Invest in Sales global headcount.
§ Invest in people, culture and talent.
§ Invest in M&A capability and execution.
· Announced a minority investment by Inflexion Private Equity Partners LLP ('Inflexion') for a 40% stake in our Healthcare division, with anticipated completion in Q2 2024
o 40% stake for expected net proceeds of £434m, valuing our Healthcare division at £1.115bn.
o Healthcare represents ~38% of Group FY23 revenues.
o GlobalData retains majority control and will continue to fully consolidate the Healthcare results post completion.
o Transformational transaction that provides flexibility for value-creating M&A.
현재 거래 및 전망
· Entering the new financial year from a position of strength in terms of revenue visibility and balance sheet.
· Initiatives to deliver accelerated growth - uncertainty driving demand for our 'gold standard' data, delivered through our One Platform.
· Continued focused approach to cost management and capital discipline, including mitigating the impact of inflation through advancements in technology and efficiency savings, whilst ensuring the business remains appropriately invested for sustainable growth and systematic M&A activity.
· FY24 이후의 명확한 재무 목표:
o Steadily progressing to 45% Adjusted EBITDA margin over the course of the plan period and reinvesting into the Growth Transformation Plan; targeting high single to double-digit organic revenue growth.
o Platform in place to accelerate inorganic growth opportunities across our three customer-focused divisions.
o Target £500m of revenue by the end of 2026, through a combination of organic growth and M&A.
1 참고 : 19페이지의 비IFRS 측정값에 대한 설명에서 정의됩니다.
2 참고 : The prior year comparatives for reported EPS, adjusted EPS and dividends have been restated to reflect the impact of the share-split, which completed on 25 July 2023 (see note 8).
의 문의
글로벌데이터 PLC | |
마이크 댄슨, CEO | + 0207 936 6400 |
Graham Lilley, 최고 재무 책임자 | |
JP모건 카제노브(노매드앤조인트) Broker) | + 0207 493 8000 |
빌 허칭스 / 모세 아디건 | |
판뮤어 고든(합동 Broker) | + 0207 886 2500 |
루퍼트 디어든 / 더기 맥러드 | |
Deutche Numis Securities (Joint Broker) 닉 웨스트레이크 / 이크라 아민
| + 0207 260 1000 |
FTI 컨설팅 LLP(재무 PR) | + 0203 727 1000 |
에드워드 브리지스 / 드와이트 버든 / 엠마 홀 |
편집자 주
GlobalData Plc 소개
GlobalData Plc(AIM: DATA)는 세계 최대 산업을 위한 최고의 데이터, 통찰력 및 분석 플랫폼입니다. 우리의 임무는 고객이 미래를 해독하고 더 나은 결정을 내리고 더 많은 고객에게 다가갈 수 있도록 돕는 것입니다.
하나의 플랫폼 모델
GlobalData의 단일 플랫폼 모델은 우리 사업의 기반이며 수년간의 지속적인 투자, 표적 인수 및 유기적 개발의 결과입니다. 이 모델은 제품을 개발하고 관리하는 방법부터 판매 및 고객 성공에 대한 접근 방식, 비즈니스 운영 지원에 이르기까지 우리가 수행하는 모든 작업을 관리합니다. 핵심적으로 이 접근 방식은 당사의 고유한 데이터, 전문가 분석 및 혁신적인 솔루션을 클라이언트 솔루션 및 디지털 커뮤니티 플랫폼의 통합 제품군에 통합하여 전 세계적으로 광범위한 산업 시장 및 고객 요구 사항을 충족하도록 설계되었습니다. 이것이 제공하는 운영 레버리지는 우리가 변화하는 고객 요구와 시장 기회에 신속하게 대응하고 제한된 자본 투자와 M&A를 위한 고유한 통합 기회를 제공하면서 대규모로 신속하게 제품을 지속적으로 관리 및 개발할 수 있음을 의미합니다.
전략적 우선 순위
GlobalData의 XNUMX가지 전략적 우선 순위는 고객 집착, 세계적 수준의 제품, 영업 우수성 및 운영 민첩성입니다.
최고 경영자의 검토
We said 2023 would be a year of 'leveraging the platform', where we intended to capitalise on the multiple levers open to us to create growth. I'm pleased to report that we have done just that and more.
Uncertainty continues to drive demand for our mission-critical data. Not only have we invested in scaling our One Platform to make it the best it can be, but we also continue to nurture and bring in talent and expertise to bolster our offering. Out of our 320 datasets, 290 are proprietary and unique to us. This valuable proprietary IP which no one else has is what sets us apart and enables our 4,810 clients, many of whom are large, blue chips to make critical and informed decisions in real time.
FY23 실적
With a continued strong performance throughout the year, GlobalData successfully delivered its near-term financial target of at least 40% Adjusted EBITDA margin. The margin progression since FY20 is symptomatic of our largely fixed cost base and high operational gearing, as well as structured integration and synergy realisation in our acquisitions. Adjusted EBITDA grew by 28% to £110.8m (2022: £86.4m) and operating profit grew by 32% to £73.7m (2022: £56.0m). Statutory profit before tax grew by 8% to £41.5m (2022: £38.4m), reflecting operating performance and net finance costs of £32.2m (2022: £17.6m).
In FY23 revenue was £273.1m (2022: £243.2m), reflecting growth of 12%, which included 7% underlying growth. Whilst the 7% underlying growth was less than our double-digit target, we remain confident in our key growth levers and are investing in our product and sales resources during FY24 and continue our ambition to target high single to double-digit organic revenue growth over the longer term.
Subscription revenue, which represents 79% of total revenue (2022: 81%), grew by 9% and 7% on an underlying basis. We continued to see strong renewal rates across our (>£20k) subscription clients, on a volume basis our renewal rates were 84% (2022: 84%). A slight reduction in price increases and upsell growth1 (which also directly impacted revenue growth), as well as the impact of currency in Q4 2023, meant that there was a small reduction in value renewal rates to 94% (2022: 101%). This is on the back of strong pricing growth through 2022.
We enter the new financial year with c.80% revenue visibility for FY24. Securing multi-year contracts remains our key focus.
성장 최적화 계획
Over the last four years, our Growth Optimisation Plan moved the business forward in multiple ways. Executing on our four strategic pillars, we have built a world-class, multi-industry platform with mission critical data, analytics and insights across 20 industries that is scalable and is ideally positioned to integrate new datasets and content into our existing vertical offering or expand our breadth into new vertical markets.
Through our relentless focus on our key growth areas - Customer Obsession, World Class Product, Sales Excellence and Operational Agility - we have scaled GlobalData to deliver £273.1m of revenues in FY23 and in executing the plan, generated significant value for the Group through focused initiatives and delivery against both organic and inorganic objectives.
Revenue on an organic basis grew by CAGR 9% FY20-FY23, with additional revenue from M&A (~£40m) delivering an overall revenue CAGR of 15%.
1) 고객 집착
Through our ongoing focus on customers, we have fostered strong relationships which took our total customer number to 4,810, with growth coming from larger clients (>£20k). We have set a target to increase the volume of renewal rates to more than 90% over the medium term, having delivered 84% in FY23.
With Artificial Intelligence advancements helping to drive customer success, our customer engagement intelligence is helping us to target specific recommendations for clients such as flagging relevant content and customising solutions. Initiatives are constantly underway to ensure our people are engaging with customers as much as possible, to understand customer needs in order to pivot towards a more solutions-based approach. The combination of Artificial Intelligence and human expertise sets us apart from peers.
1Selling more seats and product to existing customers
2) World Class Product
Our continued investment in Artificial Intelligence has enhanced our customer proposition, and we are excited about the opportunity to improve usability, driving even greater customer engagement in the years ahead. We have a clear Artificial Intelligence roadmap focused on the four areas of usability, automation, new products and internal processes all of which supported our Growth Optimisation Plan.
This year significant expansion of Artificial Intelligence coverage has been underway. The team is focused on continuously improving our products with an 'AI Hub' launched in Q4, providing natural language Q&A and dataset access. Artificial Intelligence powered prompt cards have been developed to generate reports in real-time for our clients, giving them timely access to solutions to complex requests, improving client user experience and satisfaction.
3) 판매 우수성
Our sales teams are focused on pulling key levers for growth with an ambitious target to take our volume renewal rate in our larger clients (>£20k) from 84% to over 90%, through increasing client engagement and enhancing client and user experience. During the year, in addition to selling more seats and product to existing customers, we had a net increase in the number of larger clients (>£20k) to 2,703 (2022: 2,632), a year-on-year increase of 3%. Our value renewal rate stood at 94%. Our Invoiced Forward Revenue position and new business pipeline remain healthy, and with investment in new sales roles, we are well placed to drive forward and deliver on sales excellence.
We are increasingly using Artificial Intelligence driven tools across a number of areas to retain existing clients and grow our partnerships as well as win new clients. Actively using Artificial Intelligence tools to monitor the health of our client relationships, as well as to help coach our sales teams, to personalise the selling process and to increase co-ordination across our teams, is producing tangible results.
In 2023, having launched the 'Decoded' GlobalData newsletter we now have over 750,000 newsletter subscribers.
As we become ever more embedded into our clients' business activities, we continue to see a significant opportunity to add greater value to our existing clients, including via sales synergies in acquired businesses. Our addressable market is substantial. We believe there are more than 125,000 client opportunities, compared to our existing 4,810 customers, with significant latent growth potential in the US and professional services markets.
4) 운영 민첩성
We remain focused in our approach to cost management, resource allocation and capital discipline, whilst also ensuring the business remains appropriately invested for sustainable growth, and strategic M&A activity. We are a highly cash generative business, and our business model remains attractive to credit providers due to our ability to deleverage quickly. This gives us access to capital to fund acquisitions to scale our business.
Our growth has been maintained by our continued focus on M&A, with eight acquisitions completed during the plan, and 25 since 2015. As well as our commitment to continuous organic investment in our product, the recent acquisitions of Life Sciences, LMC, MBI and TS Lombard have all added high value data and insights to our platform. The launch of new Themes proposition across all Intelligence Centers significantly improved macro themes coverage, provided by TS Lombard.
Importantly, we have set ourselves up for continued success in the attractive markets in which we operate. The transformative Healthcare transaction announced in December will provide us with the flexibility to speed up our ambitious growth acceleration plans.
A transformative deal in our Healthcare business
On 21 December 2023, Inflexion Private Equity Partners LLP ('Inflexion') exchanged on a transaction to acquire a 40% minority shareholding in GlobalData's Healthcare division and is expected to generate net proceeds at completion of approximately £434m. The investment by Inflexion, a leading investor in the sector, represents a strong endorsement and provides a meaningful partner to accelerate the Healthcare division's growth.
Whilst the deal underscores the value of GlobalData's assets and an implied value for our Healthcare division of £1,115m, it will also enable us to:
· Increase investment in product development and Artificial Intelligence;
· Strengthen our balance sheet;
· Provide additional flexibility to accelerate value-creating M&A across the Group; and
· Continue investing in our talent development and pipeline.
The deal is expected to close by the end of Q2 2024, upon fulfilment of the Conditions Precedent set out within the share options agreement.
New Growth Transformation Plan - 2024 to 2026
Having completed our Growth Optimisation Plan earlier than expected, we are now focused on our next growth chapter.
Following a detailed review of our growth opportunity, we announced our new Growth Transformation Plan alongside our transformative deal in December, which will significantly expand GlobalData's scale. This is building on the good foundational work done to date and further accelerating implementation.
Building on our success to date, and with multiple levers for growth, we will be focusing on:
· Getting even closer to our customers;
· Targeting a hugely material organic growth opportunity (a total addressable market of c.£20 billion);
· Adopting transformational Artificial Intelligence; and
· Investing in transformational M&A.
1) 고객중심주의는 우리의 최우선 과제입니다.
We strive to be the 'go-to' strategic partner to our end-markets and deliver exceptional value to our customers. As we seek to elevate our customer-focused approach throughout the Group and drive value-enhancing revenue and margin expansion, we reorganised our structure at the beginning of FY24 to create three new customer-focused business divisions:
Healthcare, Consumer and Technology.
Our market-led divisions have dedicated teams with individual management accountable for delivering against our new plan. Our sales and product teams remain focused on targeting specific end-markets, whilst having access to our Group technology and platform capabilities, plus support from our corporate teams.
This reorganisation will be underpinned by the move to a solution-based sales model, where the combination of our Artificial Intelligence capability and proprietary data enables us to provide comprehensive intelligence solutions to our customers more quickly and efficiently. Our realignment around customer solutions will bring new workflow tools and new content sets with enhanced integration, providing the ability to improve the overall usability of our products and customer experience.
Ultimately, we will focus on delivering significant increase in client engagement across all teams. Whilst expanding our sales force, we are also going to increase analyst engagement, with a view to take our analyst-client interactions to more than 30,000 in 2024 (vs 20,000 in 2023), and consultant-client interactions to more than 20,000 in 2024 (vs 8,000 in 2023).
Looking ahead, we remain laser focused on progressing our key different areas of Customer Obsession.
2) Continued focus on investment in product development and Artificial Intelligence capability
As part of our renewed focus on growth acceleration, we will continue to create value through product development. As such, our investment will be evenly spread across core product enhancements and Artificial Intelligence capability.
First and foremost, every year we will maintain a step change in the product capabilities that we have, by adding extra functions and capabilities to our offering. We will also be focusing on enhancing and expanding our proprietary data offering, and we are already seeing a 27% increase in proprietary data.
Our competitive differentiation is a key value driver, and we continuously invest in new data types. Since 2019, we saw a c.40% growth in high-value statistical data assets.
Since 2017, our successful track record of investing in Artificial Intelligence to drive usability, automation, new product development and internal process improvement provides a strong foundation to build on. We have a comprehensive Artificial Intelligence strategy and product roadmap to improve productivity and enhance customer experience. Our Artificial Intelligence driven tool 'AI Hub' launched in Q4, is providing natural language Q&A and dataset access to our customers, and has received positive feedback. It also has the potential to accelerate sales growth with new accounts. We are also developing Artificial Intelligence powered prompt cards to generate reports in real-time, reducing analyst time and improving client satisfaction.
Underpinning all that, we are looking to improve our data science and Artificial Intelligence teams to deliver the next phase of growth. We are upskilling our workforce with Artificial Intelligence training sessions tailored to functional roles and planning to have 300 Artificial Intelligence experts employed by GlobalData by 2025. Currently, we have around 300 software specialists, of which around 50 are focusing on Artificial Intelligence.
3) Maintaining our sales excellence to drive organic growth
In addition to product enhancements, our sales teams are also being set up to capture the significant market opportunity through our organic value creation plan. This will be underpinned by our continuous focus on increasing volume renewal rates to our 90% ambition, with a c.10% contribution to year-on-year sales growth.
There are multiple levers we can pull. Focusing on price increases and product improvements, selling more seats as part of our licencing model, product upsell and cross-sell opportunities, and increased new logo sales will help drive success here. We expect new logo wins to deliver c.30% contribution to year-on-year sales growth, and we consider there is headroom for growth in all areas; we have identified around 125,000 prospects, whilst currently we have 4,810 customers.
This will be supported by a rigorous focus on execution and performance management, supported by significant investment in expanding our front-line sales teams. We are targeting more than 150 additional salespeople during the Growth Transformation Plan to deliver on our promises.
4) Maintaining our operational agility through strategic M&A
We have a strong track record of highly accretive M&A. The planned investment by Inflexion in our Healthcare business will provide us with the ability and firepower to support strategic, value-enhancing acquisitions across the three business divisions.
With an ongoing disciplined approach to cost, the transformational Inflexion deal will take the Group from 2.2x Net Leverage to a Net Cash position of c.£184m. Post-completion, the Group will have a strong balance sheet to fund strategic M&A and additional free cash flow to reinvest in the business. As appropriate, it also retains the flexibility to conduct share buy backs.
우리 동료들
Our year of 'leveraging the platform' has been very successful and that has been driven by the continued focus and dedication of our growing GlobalData team. Together, we have achieved remarkable milestones and surpassed expectations, completing our Growth Optimisation Plan a year early. As we continue to invest in our people's development, we turn our attention to the next phase of our growth via our new Growth Transformation Plan - where we will accelerate the speed at which we execute - and expect to celebrate further achievements in 2024 and beyond.
By nurturing our team's skills and expertise, particularly around Artificial Intelligence, our colleagues will undoubtedly play a pivotal role in shaping the future of GlobalData. I would like to take the opportunity to welcome our new colleagues and thank all my GlobalData team for their passion and determination to not only stay ahead of the curve but also ensure that our customers receive unparalleled value.
We are significantly investing in our talent development initiatives, led by our new Chief People Officer, Katherine Lunn, who will focus on enhancing the employee proposition. She will also lead on the investment in and recruitment of new Sales specialists and AI experts, both of which are a key part of the Growth Transformation Plan.
현재 거래 및 전망
With c.80% revenue visibility and robust profitability, we enter the new financial year from a position of strength. In the new financial year, we aim to steadily progress our Adjusted EBITDA margin whilst investing into the Growth Transformation Plan to target high single to double-digit organic revenue growth. Our annual revenue target by the end of the 3-year Growth Transformation Plan is to surpass £500m.
With our business structure re-organised into three customer-focused divisions at the beginning of 2024 - Healthcare, Consumer and Technology - our platform is in a good place to accelerate organic growth opportunities as well as through strategic M&A.
Our recent deal with Inflexion underscores the strength and value of our business and will support our ambitions, providing us with the flexibility and additional funds to continue investing in innovating our product and nurturing our people. With an experienced team, we have the capability and, as we continue to expand our business, we now also have the firepower to accelerate our growth over the next three years and scale our platform.
마이크 댄슨
최고 경영자(CEO)
월 4 2024
최고 재무 책임자의 검토
£ m | 연말 31 12월 2023 | 연말 31 12월 2022 | ||||
수익 | 273.1 | 243.2 | ||||
영업 이익 | 73.7 | 56.0 | ||||
감가 상각 | 6.2 | 6.4 | ||||
취득한 무형자산의 상각 | 9.0 | 9.1 | ||||
소프트웨어 상각 | 1.6 | 1.0 | ||||
주식기준보상수수료 | 19.4 | 4.1 | ||||
주식기준보상제도와 관련된 비용 | 0.2 | 0.9 | ||||
구조조정 및 재융자 비용 | 1.7 | 2.5 | ||||
단기파생상품 및 장기파생상품의 재평가(이익)/손실 | (0.8) | 0.6 | ||||
미실현 영업외환(이익)/손실 | (1.5) | 1.9 | ||||
M&A 및 조건부 대가 비용 | 1.3 | 3.9 | ||||
조정 EBITDA1 | 110.8 | 86.4 | ||||
조정 된 EBITDA 마진1 | 41% | 36% | ||||
세전 법정 이익 | 41.5 | 38.4 | ||||
취득한 무형자산의 상각 | 9.0 | 9.1 | ||||
주식기준보상수수료 | 19.4 | 4.1 | ||||
주식기준보상제도와 관련된 비용 | 0.2 | 0.9 | ||||
구조조정 및 재융자 비용 | 1.7 | 2.5 | ||||
단기파생상품 및 장기파생상품의 재평가(이익)/손실 | (0.8) | 0.6 | ||||
미실현 영업외환(이익)/손실 | (1.5) | 1.9 | ||||
M&A 및 조건부 대가 비용 | 1.3 | 3.9 | ||||
금리스왑 재평가 | 2.8 | - | ||||
세전 조정 이익1 | 73.6 | 61.4 | ||||
조정 법인세 비용1 | (18.5) | (12.6) | ||||
세후 조정 이익1 | 55.1 | 48.8 | ||||
|
| |||||
영업에서 발생하는 현금 흐름 | 101.0 | 85.4 | ||||
이자 지급 | (23.0) | (14.0) | ||||
납부 한 소득세 | (12.0) | (9.5) | ||||
조건부 대가 지급 | (0.2) | - | ||||
리스 지불의 주요 요소 | (5.4) | (5.9) | ||||
무형 및 유형 자산의 구매 | (4.2) | (2.7) | ||||
무료 현금 흐름1 | 56.2 | 53.3 | ||||
영업현금흐름 환산%1 | 91% | 99% | ||||
잉여현금흐름전환 %1 | 76% | 87% | ||||
|
| |||||
Earnings attributable to equity holders (restated2) : |
| |||||
기본 주당순이익(펜스) | 3.8 | 3.8 |
| |||
희석 주당 순이익(펜스) | 3.8 | 3.7 |
| |||
조정된 기본 주당순이익(펜스) | 6.8 | 6.1 |
| |||
조정 희석 주당 순이익(펜스) | 6.7 | 5.9 |
| |||
1 19페이지의 비IFRS 측정값에 대한 설명에서 정의됩니다.
2 The prior year comparatives on basic and diluted earnings per share on both a reported and an adjusted basis have been restated to reflect the impact of the share-split, which completed on 25 July 2023 (see note 8).
핵심 성과 지표:
재무 핵심 성과 지표
The financial KPIs detailed below are used, in addition to statutory reporting measures, by the Executive Directors to monitor the Group's performance and progress.
| 수익
| 인보이스 전달 수익 | 조정 EBITDA | 조정 된 EBITDA 마진 | 순 은행 부채
|
2023 | £ 273.1m | £ 135.2m | £ 110.8m | 41% | £ 243.9m |
2022 | £ 243.2m | £ 133.5m | £ 86.4m | 36% | £ 249.6m |
보고된 성장률 | 12% | 1% | 28% | +5p.p. | -2 % |
% 기본 성장 | 7% | 4% | 23% | +6p.p. | N / |
The platform economics of our business model meant that we continued to see a large flow through of incremental revenue to Adjusted EBITDA without material incremental cost of sale. Over the course of the past four years we have seen material margin improvement in the business, and we are now reporting an Adjusted EBITDA margin in excess of 40%, at 41%.
We finished the year with good visibility on future revenues, following another strong year of revenue growth. Invoiced Forward Revenue grew to £135.2m (underlying growth of 4%) at 31 December 2023 (31 December 2022: £133.5m), overall visibility (including contracted and renewable revenues) grew on an underlying basis by 6%.
The 6% underlying growth on revenue visibility is based upon the underlying growth in Invoiced Forward Revenue (which excludes the impact of currency) of 4%, plus growth in the visibility we have on 2024 contracted revenue that has not yet been invoiced and the revenue expectation from our renewing clients in 2024 (on the assumption of consistent renewal rates).
운영 핵심 성과 지표
As at 31 December 2023, the total number of clients (>£5,000 spend) grew 2% to 4,810 (2022: 4,735).
| 클라이언트 > £20,000 | 모든 고객 (5,000파운드 이상) | ||||
| 가치 갱신 비율 | 볼륨 리뉴얼 율 | 평균 고객 가치 | 가치 갱신 비율 | 볼륨 리뉴얼 율 | 평균 고객 가치 |
2023 | 94% | 84% | £76,157 | 94% | 80% | £48,714 |
2022 | 101% | 84% | £75,100 | 99% | 78% | £47,900 |
운동 | -7pp | - | 1% | -5pp | +2p.p. | 2% |
Our volume renewal rates improved overall year on year, as we continue to progress towards our stated ambition of volume renewal rates of >90%. We continue to focus on our number one strategic priority of customer obsession and have several initiatives in play, which are all looking to strengthen customer relationships and value derived from our product.
Adverse currency impact in the fourth quarter of 2023 ('Q4') (GBP strengthening versus USD) meant that our value renewal rates were impacted, as well as some softening on price increases achieved in the second half of the year. We increased the net number of clients by 2% to 4,810, as well as overall average client value increasing to £48,714 (2022: £47,900), also adversely impacted by currency movements in Q4.
Financial Review Notes
The financial position and performance of the business are reflective of the key financial elements of our business model: visible and recurring revenues, high incremental margins, scalable opportunity and strong cash flows. The Directors believe that Adjusted EBITDA, Adjusted EBITDA margin, Adjusted profit before tax, Adjusted profit after tax and Adjusted earnings per share provide additional useful information on the operational performance of the Group to shareholders, and internally we review the results of the Group using these measures. The term 'adjusted' is not a defined term under IFRS and may not therefore be comparable with similarly titled profit measures reported by other companies. It is not intended to be a substitute for, or superior to, IFRS measures of profit.
The Directors also believe that reviewing revenue growth on an 'underlying' basis gives a useful view on the performance of the business. By reviewing growth excluding the impact of currency and the impact of acquisitions, the Directors can review performance on a like-for-like basis. The term 'underlying' is not a defined term under IFRS and may not therefore be comparable with similarly titled measures reported by other companies.
Financial Key Performance Indicators ('KPIs') The financial KPIs on page 10 are used, in addition to statutory reporting measures, by the Executive Directors to monitor the Group's performance and progress. These key performance indicators are used to measure progress against strategy, the strength of the business and long-term prospects for our stakeholders.
운영 핵심 성과 지표 The operational key performance indicators below are used by the Directors to monitor the quality of revenue growth and understand underlying performance. Our operational key performance indicators are:
Value Renewal Rate - this is calculated in refence to the total spend of existing clients with subscription contracts in the last twelve months, compared to the total spend of those same clients in the twelve months prior to that.
Volume Renewal Rate - this is calculated in refence to the number of existing clients with subscription contracts in the last twelve months, compared to the same number of clients in the twelve months prior to that.
Average Client Value - this is calculated using the total value of sales across our clients with subscription contracts and dividing by the number of clients with subscription contracts, which shows an average value.
우리의 운영 KPI는 수익이 아닌 판매 주문을 참조하므로 해당 연도에 인식된 수익과 송장 전달 수익 모두에 영향을 미칩니다.
|
올해 그룹 실적
1. 수익
Revenue grew by 12% to £273.1m (2022: £243.2m). The majority of the increase came from underlying growth of 7%, aided by 4% benefit from acquisitions and 1% currency benefit. On an underlying basis, subscriptions (representing 79% of revenue (2022: 81%)) grew by 7% underpinned by strong renewal rates, and new business wins. The change in subscription revenue mix compared with 2022 was driven by the impact of acquisitions.
2. 과세 전 소득
Profit before tax for the year grew by £3.1m to £41.5m (2022: £38.4m), which represents stronger operating performance at an Adjusted EBITDA level being offset with increases in other operating costs, namely share-based payments (a year on year increase of £15.3m as a result of changes in the schemes target basis in 2022 giving rise to updated fair values of options) and higher finance costs (+£14.6m), reflecting an increase in average drawn debt in 2023 compared with 2022 and higher interest rates.
£ m | 연말 31 12월 2023 | 연말 31 12월 2022 | % 변경 |
수익 | 273.1 | 243.2 | 12% |
운영 비용 | (162.3) | (156.8) | 4% |
조정 EBITDA | 110.8 | 86.4 | 28% |
감가 상각 | (6.2) | (6.4) | -3 % |
취득한 무형자산의 상각 | (9.0) | (9.1) | -1 % |
소프트웨어 상각 | (1.6) | (1.0) | 60% |
주식기준보상수수료 | (19.4) | (4.1) | 373% |
주식기준보상제도와 관련된 비용 | (0.2) | (0.9) | -78 % |
재융자 비용 | - | (1.9) | -100 % |
구조 조정 비용 | (1.7) | (0.6) | 183% |
Revaluation gain/(loss) on short and long-term derivatives | 0.8 | (0.6) | -233 % |
Unrealised operating foreign exchange gains/(losses) | 1.5 | (1.9) | -179 % |
M&A 비용 | (0.4) | (2.9) | -86 % |
우발적 고려 | (0.9) | (1.0) | -10 % |
금융 비용 | (32.2) | (17.6) | 83% |
과세 전 소득 | 41.5 | 38.4 | 8% |
조정 EBITDA
Adjusted EBITDA increased by 28% to £110.8m (2022: £86.4m). The revenue growth of £29.9m (£17.2m of which was underlying growth) was offset with cost increases of £5.5m (largely representing the full year impact of acquisitions which closed mid-way through 2022), meaning that the overall net improvement to Adjusted EBITDA was £24.4m (incremental margin of 82%). The growth in Adjusted EBITDA is reflective of the operational gearing in our business model and our ability to control what is a relatively fixed cost base. Our overall margin increased by 5 percentage points to 41% (2022: 36%).
On an underlying basis, Adjusted EBITDA grew by 23% and Adjusted EBITDA margin increased by 6 percentage points, which is reconciled below.
£ m | 2023 | 2022 | 성장 |
보고 된 수익 | 273.1 | 243.3 |
|
통화 움직임 다시 추가 | (3.5) | - |
|
Add back pre-acquisition revenue of M&A | - | 9.1 |
|
Revenue underlying | 269.6 | 252.4 | 7% |
|
|
|
|
Adjusted EBITDA as reported | 110.8 | 86.4 |
|
통화 움직임 다시 추가 | (1.4) | - | |
Add back pre-acquisition Adjusted EBITDA of M&A | - | 2.3 | |
Adjusted EBITDA underlying | 109.4 | 88.7 | 23% |
|
|
|
|
Adjusted EBITDA margin underlying | 41% | 35% | 6pp |
조정 항목
조정 품목은 총 6.3만 파운드 증가했으며 몇 가지 중요한 개별 움직임이 있습니다.
· The share-based payment charge has increased from £4.1m to £19.4m, which is mainly driven by the modification to targets made during 2022 giving rise to a higher fair value per option, plus a net increase in the number of options in issue during 2023. The modification was effective from 30 November 2022 and therefore only had an impact of £0.5m increase in charge in the previous year.
· M&A costs reduced year on year, from £2.9m to £0.4m, reflective of no M&A during 2023.
· Unrealised foreign exchange gains of £2.3m were recognised during the year, in comparison with a total loss in 2022 of £2.5m.
금융 비용
Finance costs have increased by 83% to £32.2m (2022: £17.6m) which is inclusive of a non-cash interest charge of £5.1m relating to financial liabilities measured at amortised cost (2022: £2.1m), revaluation loss on interest rate swap of £2.8m (2022: £nil) and IFRS16 leases interest of £1.1m (2022: £1.3m). The cash paid in interest in 2023 was £23.0m (2022: £14.0m) reflecting an increase in average drawn debt in 2023 compared with 2022 and higher interest rates.
Finance costs are calculated on drawn debt based upon a margin range of 275-375bps, dependent on Group net leverage, plus SONIA (Sterling Overnight Index Average rate). The Group entered into a swap arrangement on SONIA on 21 October 2022 amid the backdrop of rising rates. The arrangement fixed SONIA at 4.9125% over the remaining life of the term loan. Undrawn debt carries interest at one third of the prevailing margin.
임대
Within our operating costs, depreciation in relation to right-of-use assets was £5.1m (2022: £4.7m). Our net finance costs include interest of £1.1m in relation to lease liabilities (2022: £1.3m).
3. 결과에 미치는 외환 영향
The Group derives around 60% of revenues in currencies other than Sterling, compared with around 40% of its cost base. The impact of currency movements in the year increased revenue by £3.5m, which mainly reflected Sterling weakness against US Dollar (average rate: 2023: 1.23, 2022: 1.25), with £3.3m currency headwind also reflected in Invoiced Forward Revenue. Cost inflation as a result of currency movements largely offset the gain in the year and impacted the results by £2.1m. The full impact of currency on Adjusted EBITDA was an increase of £1.4m.
£ m | 수익 | 운영 비용1 | 조정 EBITDA | 조정 EBITDA 한계
| 인보이스 전달 수익 |
보도 된 바와 같이 | 273.1 | (162.3) | 110.8 | 41% | 135.2 |
통화 움직임 다시 추가 | |||||
미국 달러 | (3.5) | 3.7 | 0.2 | 3.3 | |
유로 | (0.3) | 0.1 | (0.2) | (0.1) | |
기타 | 0.3 | (1.7) | (1.4) | 0.1 | |
일정한 통화 | 269.6 | (160.2) | 109.4 | 41% | 138.5 |
2022년 - 보고된 대로 | 243.2 | (156.8) | 86.4 | 36% | 133.5 |
지속적인 통화 성장 | 11% | 2% | 27% | 5.pp | 4% |
1항목 조정을 제외한 운영 비용.
4. 과세
The Group's effective income tax rate (ETR) for the reporting period is 25.8% which exceeds the blended statutory UK income tax rate for the period of 23.5%. The major components increasing the ETR are expenses non-deductible for tax purposes and local withholding taxes chargeable on the distribution of profits from overseas subsidiaries.
기본 이익의 백분율로 그룹의 미래 세금 부과에 영향을 미칠 수 있는 주요 요소는 그룹이 운영되는 관할 구역 간의 손익 혼합과 해당 지역의 해당 세율, 공제되지 않는 지출 및 비공제 비용의 영향입니다. 과세 소득 및 이전에 인식되지 않은 이연 법인세 자산의 활용 (현금 세금 납부액 감소).
조정 소득세 부과금에 대한 법정 소득세 부과금 조정은 다음과 같습니다.
£ m | 연말 31 12월 2023 | 연말 31 12월 2022 |
법정 소득세 부과 | 10.7 | 7.9 |
취득한 무형자산의 상각 | 1.9 | 1.8 |
주식기준보상수수료 | 4.8 | 0.8 |
주식기준보상제도와 관련된 비용 | - | 0.2 |
구조조정 및 재융자 비용 | 0.3 | 0.4 |
미실현 영업외환(이익)/손실 | (0.6) | 0.5 |
금리스왑 재평가 | 0.7 | - |
법인세율 변경 | 0.4 | 1.3 |
인식되지 않은 이연법인세의 이동 | 0.3 | (0.3) |
조정 소득세 부과 | 18.5 | 12.6 |
5. 주당 순이익
Pursuant to a capital reorganisation exercise undertaken on 25 July 2023, the Company issued nine ordinary shares to increase the number of ordinary shares in issue to 118,303,878 (nominal value £0.000714 per share). All existing ordinary shares were then consolidated, based on 1 consolidated share for every 14 existing ordinary shares, and subdivided, based on 100 new ordinary shares for every 1 consolidated share. Post-reorganisation, there were 845,027,700 ordinary shares in issue (nominal value £0.0001 per share) which were admitted to AIM and commenced dealing on 26 July 2023. The prior year comparatives on basic and diluted earnings per share on both a reported and an adjusted basis have been restated to reflect the impact of the share-split as required by IAS 33: Earnings per share.
Basic EPS was 3.8 pence per share (2022 restated: 3.8 pence per share). Fully diluted profit per share was 3.8 pence per share (2022 restated: 3.7 pence per share). Adjusted basic earnings per share grew from 6.1 pence per share to 6.8 pence per share, representing 11% growth.
Growth in Adjusted earnings per share (+11%) fell behind the growth in Adjusted EBITDA (+28%) mainly as a result of increased finance charges in the year. Cash interest charges increased by £9.0m (+64%) as well as non-cash finance costs increasing by £5.6m compared with 2022. Non-cash finance charges include non-cash interest relating to financial liabilities measured at amortised cost of £5.1m (2022: 2.1m). The increased charge in the year reflects the change in anticipated cash flows on the term loan (full repayment of the loan is expected upon completion of the investment agreement with Inflexion).
6. 배당
We are pleased to propose a final dividend of 3.2 pence per share (2022 회복: 2.6 pence), to be paid on 26 April 2024 to shareholders on the register at the close of business on 22 March 2024. The ex-dividend date will be on 21 March 2024. The proposed final dividend increases the total dividend for the year to 4.6 pence per share (2022 회복: 3.6 pence), an increase of 28%.
7. 현금 창출
Cash generated from operations grew by 18% to £101.0m (2022: £85.4m), representing 91% of Adjusted EBITDA (2022: 99%).
Capital expenditure was £4.2m in 2023 (2022: £2.7m), including £3.2m on software including assets under construction (2022: £1.7m). Capital expenditure represented 1.5% of revenue (2022: 1.1%).
Total cash flows from operating activities were £65.8m (growth of £3.9m from 2022), which represented 89% of operating profit (2022: 111%). During the year, the Group paid out £32.2m in dividends (2022: £23.6m).
Short- and long-term borrowings decreased by £19.9m to £263.7m as at 31 December 2023 (2022: £283.6m).
8. 순 은행 부채:
Net bank debt decreased to £243.9m as at 31 December 2023 (2022: £249.6m).
The Group defines net bank debt as short- and long-term borrowings (note 10) less cash and cash equivalents. The amount excludes items related to leases.
£ m | 2023 | 2022 |
|
|
|
단기 및 장기 차입금(주석 10) | 263.7 | 283.6 |
현금 | (19.8) | (34.0) |
순 은행 부채 | 243.9 | 249.6 |
운영, 잉여현금흐름, 개설 및 마감 순 은행 부채에서 창출된 현금의 조정은 아래에 설명되어 있습니다.
£ m | 31년 2023월 XNUMX일 종료 | 연말 31 12월 2022 | 성장 |
영업에서 발생하는 현금 흐름 | 101.0 | 85.4 | 18% |
이자 지급 | (23.0) | (14.0) | 64% |
납부 한 소득세 | (12.0) | (9.5) | 26% |
조건부 대가 지급 | (0.2) | - | 100% |
리스 지불의 주요 요소 | (5.4) | (5.9) | -8 % |
무형 및 유형 자산의 구매 | (4.2) | (2.7) | 56% |
무료 현금 흐름 | 56.2 | 53.3 | 5% |
배당금 지급 | (32.2) | (23.6) | 36% |
순M&A | - | (33.6) | -100 % |
자기주식취득 | (11.9) | (66.6) | -82 % |
대출금 상환으로 받은 현금 | - | 0.9 | -100 % |
순 현금 흐름 | 12.1 | (69.6) | -117 % |
은행순부채 개설 | (249.6) | (177.6) | 41% |
차입금의 비현금 이동 | (5.1) | (2.1) | 143% |
통화 환산 | (1.3) | (0.3) | 333% |
순 은행 부채 마감 | (243.9) | (249.6) | -2 % |
지난 12개월 조정 EBITDA | 110.8 | 86.4 | 28% |
순 은행 부채 레버리지 | SR 2.2x | SR 2.9x | -0.7x |
9. 인보이스 전달 수익
Invoiced Forward Revenue grew to £135.2m (reported growth of 1% and underlying growth of 4% when the impact of currency is excluded as noted in section 3 of this financial review) at 31 December 2023 (2022: £133.5m).
£ m | 2023 | 2022 |
|
|
|
이연 수익 | 104.6 | 104.0 |
미결제 금액/구독이 31월 XNUMX일에 시작되지 않음 | 30.6 | 29.5 |
인보이스 전달 수익 | 135.2 | 133.5 |
10. 무형 자산
Intangible assets (excluding goodwill) have decreased by £7.3m during the year, from £69.0m as at 31 December 2022 to £61.7m as at 31 December 2023. This movement is driven by an amortisation charge for the year of £10.6m (2022: £10.1m) offset by additions of £3.3m (2022: £1.7m).
11. 매출 채권
Net trade receivables as at 31 December 2023 were £54.8m, representing 1% growth compared with the 31 December 2022 balance of £54.4m.
전년도 재작성
Following a routine Financial Reporting Council ("FRC") review of the consolidated financial statements for the year ended 31 December 2022, the Group engaged with the FRC which resulted in a restatement of the Consolidated Statement of Cash Flows to present the settlement of the previous term loan and Revolving Credit Facilities ("RCF"), the proceeds from the new term loan and the loan fees incurred on the new facility as a net financing cash inflow of £53.5m within proceeds from borrowings. The amounts in respect of this transaction were previously presented gross. Following a reassessment of the specific cash flow arrangements this restatement reflects that the cash inflow actually occurred on a net basis. The restatement involves a reclassification adjustment to three lines within the Cash flows from financing activities section of the Consolidated Statement of Cash Flows with a £nil net impact on the Group's Cash flows from financing activities and a £nil net impact on the Group's financial position and performance. We welcomed the FRC's review and have set out the details of the restatement in the Accounting Policies of the Group's Annual Report and Accounts for the year ended 31 December 2023.
Minority investment in the Group's Healthcare business expected to complete in Q2 2024
On 21 December 2023, the Group announced that it had exchanged on a transaction to sell 40% of the Group's Healthcare business to Inflexion. We have assessed the accounting implications for the Group arising from the transaction in respect of the year ended 31 December 2023. We have taken into consideration the specific details set out in both the Share Option Agreement and Co-Investment Agreement and concluded that following completion of the transaction, GlobalData Plc will continue to have control of the Healthcare business, the results of which will therefore continue to be fully consolidated into the results of the GlobalData Plc Group and the Group will recognise a non-controlling interest within equity in the Group's Statement of Financial Position. We have concluded that the completion date will be the point at which the put and call options detailed within the Share Option Agreement are exercised and as at 31 December 2023 this has not taken place.
재무 위험 관리
환 위험을 관리하는 연결실체의 주요 목표는 궁극적인 스털링 순 현금 흐름이 외화 환율 변동에 의해 영향을 받을 위험으로부터 보호하는 것입니다. 이를 위해 그룹은 스털링과 미국 달러 및 유로 환율 변동으로 인한 위험을 제한하는 외환 계약을 체결합니다. 그룹의 인도 사업으로 인해 그룹은 인도 루피 환율과 함께 미국 달러의 움직임으로 인한 위험을 제한하는 외환 계약도 체결합니다. 상업적으로 그리고 현금 흐름의 관점에서 이것이 연결실체의 통화 익스포저를 헤지하는 반면, 연결실체는 헤지 회계를 적용하지 않기로 선택하고 이에 따라 외환 계약의 공정 가치 변동은 손익계산서에 인식됩니다.
As a data and analytics company, cross border tariffs have a limited impact on our business. However, the Group continues to observe ongoing OECD initiatives and frameworks with respect to the challenges arising from the taxation of the digital economy. In particular, the introduction of Pillar One (determining where tax should be paid and on what basis) and Pillar Two (the design of a system that ensures multinational enterprises pay a minimum level of tax) is being monitored, however as the application thresholds are aimed at the very largest companies, the rules are unlikely to impact the Group.
이자율 위험
Interest rate risk is the impact that fluctuations in market interest rates can have on the value of the Group's interest-bearing assets and liabilities and on the interest charge recognised in the income statement. On 21 October 2022, GlobalData Plc (the parent company) entered into an interest rate swap arrangement to fix the floating element of the interest rate (based upon SONIA) to a fixed rate of 4.9125%. Up to 21 December 2023, the Group applied hedge accounting in accordance with IFRS9 (Financial Instruments); as such any gains or losses on the interest rate swap, to the extent that they are effective, were recognised directly within other comprehensive income of both the Group and the parent company. Since 21 December 2023, upon exchange of the transaction to sell 40% of the Group's Healthcare business, it is now the Group's intention to fully repay the loan upon completion of the investment agreement with Inflexion. Given the hedged items (future interest repayments) are no longer probable or expected to occur, hedge accounting has been discontinued, and as such the cumulative balance held in the cash flow hedge reserve was transferred to the income statement.
유동성 위험 및 계속 기업
The Group's approach to managing liquidity risk is to ensure, as far as possible, that it has sufficient liquidity to meet its liabilities as they fall due, with surplus facilities to cope with any unexpected variances in timing of cash flows. The Group meets its day-to-day working capital requirements through free cash flow, being operations-generated cash (with no external financing required). Although the statement of financial position shows net current liabilities (current assets less current liabilities), included in current liabilities is £104.6m of deferred revenue that represents future income earnings. Excluding deferred revenue, the Group has net current assets of £49.8m (2022: £56.4m).
Based on cash flow projections, the Group considers the existing financing facilities to be adequate to meet short-term commitments. The Directors have a reasonable expectation that there are no material uncertainties that cast significant doubt about the Group's ability to continue in operation and meet its liabilities as they fall due for the foreseeable future, being a period of at least 12 months from the date of approval of the financial statements. Accordingly, the Group has prepared the Annual Report and Accounts on a going concern basis. The Directors have prepared a Going Concern and Long-Term Viability statement within the Group's Annual Report and Accounts for the year ended 31 December 2023, within the Strategic Report.
비IFRS 측정값에 대한 설명
재정적 조치 | 우리가 그것을 정의하는 방법 | 우리가 그것을 사용하는 이유 |
조정 된 희석 EPS | 희석주당 세후 조정 이익(9페이지에 표시된 법정 이익과 조정 이익 간의 조정). 희석주식은 기본가중평균주식수(자기보유보유주식 순액)와 기말에 발행되는 주식선택권(주석 8의 기본가중평균주식수와 희석가중평균주식수의 조정)의 합계로 정의됩니다. . | 연간 운영 비즈니스 성과를 평가하는 데 유용한 기반을 제공합니다. |
조정 EBITDA | 인수, 그룹 구조 조정, 주식 기준 지급, 손상, 미실현 영업 환율 변동 및 외환 계약의 영향과 관련된 비용을 제외하도록 조정된 이자, 세금, 감가상각비 및 상각 전 수익입니다. 이는 9페이지의 법정 영업이익과 일치합니다. | |
지난 12개월 조정 EBITDA | Earnings before interest, tax, depreciation and amortisation, adjusted to exclude costs associated with acquisitions, restructuring of the Group, share-based payments, impairment, unrealised operating exchange rate movements and the impact of foreign exchange contracts in the 12 months preceding the period end date. | |
조정 된 EBITDA 마진 | Adjusted EBITDA as a percentage of revenue. This is calculated on page 9. | |
조정 된 EPS | 주당 세후 조정 이익(법정 이익과 조정 이익 간의 조정은 9페이지 참조). | |
조정 법인세 비용 | Represents the statutory income tax expense adjusted for the tax effect on adjusting items. In addition, the adjusted income tax expense includes the effect of any tax rate changes. This is reconciled to the statutory income tax charge on page 14. | |
세전 조정 이익 | Statutory profit before tax adjusted to exclude amortisation of acquired intangible assets, costs associated with acquisitions, restructuring of the Group, share-based payments, impairment, unrealised operating exchange rate movements, the impact of foreign exchange contracts and revaluation of the interest rate swap. This is reconciled to the statutory profit before tax on page 9. | |
세후 조정 이익 | The sum of adjusted profit before tax and adjusted income tax expense. This is calculated on page 9. | |
지속적인 통화 성장 | Underlying growth is calculated by excluding the impact of movement in exchange rates. Constant currency growth is reconciled to reported growth on page 14 for revenue, operating costs, Adjusted EBITDA, Adjusted EBITDA margin and Invoiced forward revenue. | 독자에게 환율 변동의 영향 없이 비즈니스 성장에 대한 아이디어를 제공하여 결과의 투명성과 이해를 높일 수 있습니다. |
무료 현금 흐름 | Cash flow generated from operations less interest paid, income taxes paid, contingent consideration paid, principal elements of lease payments and purchase of intangible and tangible assets. This is calculated on page 9. | 그룹이 조정 이익에서 현금을 창출하는 정도를 나타냅니다. |
무료 현금 흐름 변환 | 잉여현금흐름을 세전 조정 이익으로 나눈 값입니다. This is calculated on page 9. | |
인보이스 전달 수익 | Invoiced Forward Revenue는 인식할 미래 수익과 관련하여 재무상태표 날짜에 고객에게 청구된 금액과 관련됩니다. 이는 16페이지의 이연 수익으로 조정됩니다. | 향후 기간에 대한 수익 가시성을 나타내는 역할을 합니다. |
순 은행 부채 | 단기 및 장기 차입금(리스부채 제외)에서 현금및현금성자산을 차감한 금액입니다. 이는 16페이지에 정리되어 있습니다. | 현재 현금 자원을 고려하여 그룹의 부채 상태에 대한 통찰력을 제공합니다. |
순 은행 부채 레버리지 | 지난 12개월 조정 EBITDA의 배수로 계산된 순 은행 부채입니다. 자세한 계산은 16페이지에 나와 있습니다. | |
순 현금 흐름 | Free cash flow less dividends paid, net M&A costs, acquisition of own shares and cash received from repayment of loans. This is calculated on page 16. | 그룹이 조정 이익에서 현금을 창출하는 정도를 나타냅니다. |
영업현금흐름 환산 | 영업에서 창출된 현금 흐름을 조정 EBITDA로 나눈 값입니다. 이는 9페이지에서 계산됩니다. | 그룹이 조정 EBITDA에서 현금을 창출하는 정도를 나타냅니다. |
유기적 성장 | Organic growth is calculated by excluding the results of acquired businesses. | The reason we use organic and underlying growth as a metric is to give the reader an idea of the growth of the business without the impact of acquisitions and foreign exchange fluctuations, which may add to the transparency and understanding of the results. This also aids the Directors to review performance on a like-for-like basis. |
기본 성장 | Underlying growth is calculated by excluding the impact of movement in exchange rates and the results of acquired businesses. Underlying revenue is reconciled to reported revenue on page 13. Underlying invoiced forward revenue is reconciled to reported invoiced forward revenue on page 16. Underlying Adjusted EBITDA and underlying Adjusted EBITDA margin are reconciled to reported figures on page 13. |
연결 손익 계산서
노트
| 31년 2023월 XNUMX일 종료
| 31년 2022월 XNUMX일 종료
| |
지속적인 운영 |
| £ m | £ m |
수익 | 4 | 273.1 | 243.2 |
운영 비용 | 5 | (197.7) | (186.6) |
매출채권손실 | 5 | (2.3) | (0.7) |
다른 수입 | 0.6 | 0.1 | |
영업 이익 | 73.7 | 56.0 | |
순 금융 비용 | 7 | (32.2) | (17.6) |
과세 전 소득 | 41.5 | 38.4 | |
소득세 비용 | (10.7) | (7.9) | |
올해의 이익 | 30.8 | 30.5 | |
원인 : | |||
모회사의 주주 | 30.8 | 30.5 | |
| |||
주주에게 귀속되는 주당 이익(재작성): | |||
기본 주당순이익(펜스) | 8 | 3.8 | 3.8 |
희석 주당 순이익(펜스) | 8 | 3.8 | 3.7 |
| |||
조정된 EBITDA에 대한 조정: | |||
영업 이익 | 73.7 | 56.0 | |
감가 상각 | 6.2 | 6.4 | |
소프트웨어 상각 | 1.6 | 1.0 | |
조정 항목 | 6 | 29.3 | 23.0 |
조정 EBITDA | 110.8 | 86.4 |
The earnings per share prior year comparatives have been restated to reflect the impact of the share-split, which completed on 25 July 2023 (see note 8) on basic and diluted earnings per share.
연결포괄손익계산서
| 31년 2023월 XNUMX일 종료
| 31년 2022월 XNUMX일 종료
| |
|
| £ m | £ m |
올해의 이익 | 30.8 | 30.5 | |
기타 포괄 손익 | |||
특정 조건이 충족되면 후속적으로 당기손익으로 분류되는 항목: | |||
현금 흐름 헤지 - 공정 가치 변동의 유효 부분 | 0.7 | (3.9) | |
현금흐름위험회피 - 당기손익으로 재분류 | 3.2 | - | |
외국법인 환산순환차손 | (1.3) | (0.4) | |
기타포괄손익/(손실), 세액공제 | 2.6 | (4.3) | |
당해 년도 총 포괄 이익 |
| 33.4 | 26.2 |
| |||
원인 : | |||
모회사의 주주 | 33.4 | 26.2 |
연결 재무 상태 표
노트
| 31 12월 2023 £ m | 31 12월 2022 £ m | |
비유동 자산 | |||
재산, 식물 및 장비 | 26.6 | 31.0 | |
친선 | 9 | 311.1 | 311.1 |
기타 무형 자산 | 9 | 61.7 | 69.0 |
이연 법인세 자산 | 3.4 | 2.3 | |
402.8 | 413.4 | ||
유동 자산 | |||
매출 채권 및 기타 채권 | 69.2 | 62.7 | |
당기세금 | - | 0.6 | |
단기 파생 자산 | 0.5 | 0.9 | |
현금 및 현금성 자산 | 19.8 | 34.0 | |
89.5 | 98.2 | ||
총자산 | 492.3 | 511.6 | |
유동 부채 | |||
매입 채무 및 기타 채무 | (32.4) | (33.3) | |
이연 수익 | 4 | (104.6) | (104.0) |
단기리스부채 | 10 | (4.3) | (5.4) |
현재 납부해야 할 세금 | (2.8) | (1.7) | |
단기 파생 부채 | (0.1) | (1.3) | |
단기 조항 | (0.1) | (0.1) | |
(144.3) | (145.8) | ||
순유동 부채 | (54.8) | (47.6) | |
비유동 부채 | |||
장기 조항 | (1.4) | (1.3) | |
이연 법인세 부채 | (0.9) | (4.1) | |
장기 파생 부채 | (2.8) | (3.9) | |
장기리스 부채 | 10 | (21.4) | (24.6) |
장기 차입금 | 10 | (263.7) | (283.6) |
(290.2) | (317.5) | ||
총 부채 | (434.5) | (463.3) | |
순자산 | 57.8 | 48.3 | |
공평 | |||
주식 자본 | 11 | 0.2 | 0.2 |
재무 준비금 | 11 | (65.4) | (70.8) |
기타 예비 | 11 | (44.3) | (44.3) |
현금 흐름 헤지 준비금 | 11 | - | (3.9) |
외화 환산 준비금 | 11 | (2.0) | (0.7) |
이익잉여금 | 169.3 | 167.8 | |
지배기업의 주주에게 귀속되는 자본 | 57.8 | 48.3 |
연결 자본 변동표
노트 | 주식 자본 | 재무 준비금 | 기타 예비 | 현금 흐름 헤지 준비금 | 외화 환산 준비금 | 이익잉여금 | 지배기업의 주주에게 귀속되는 자본 | |
|
| £ m | £ m | £ m | £ m | £ m | £ m | £ m |
1년 2022월 XNUMX일 잔액 |
| 0.2 | (66.6) | (44.3) | - | (0.3) | 217.3 | 106.3 |
올해의 이익 | - | - | - | - | - | 30.5 | 30.5 | |
기타 포괄 손익 : |
|
| ||||||
현금 흐름 헤지 - 공정 가치 변동의 유효 부분 | - | - | - | (3.9) | - | - | (3.9) | |
외국법인 환산순환차손 | - | - | - | - | (0.4) | - | (0.4) | |
당해 년도 총 포괄 이익 | - | - | - | (3.9) | (0.4) | 30.5 | 26.2 | |
소유자와의 거래: |
| |||||||
자사주 매입 | 11 | - | (66.6) | - | - | - | - | (66.6) |
배당 | 11 | - | - | - | - | - | (23.6) | (23.6) |
주식선택권의 부여 | 12 | - | 62.4 | - | - | - | (62.4) | - |
주식기준보상수수료 | 12 | - | - | - | - | - | 4.1 | 4.1 |
주식기준보상세 | - | - | - | - | - | 1.9 | 1.9 | |
31 년 2022 월 XNUMX 일 잔액 |
| 0.2 | (70.8) | (44.3) | (3.9) | (0.7) | 167.8 | 48.3 |
올해의 이익 | - | - | - | - | - | 30.8 | 30.8 | |
기타 포괄 손익 : |
|
| ||||||
Cash flow hedge - reclassification to profit or loss upon loan repayment | - | - | - | 0.4 | - | - | 0.4 | |
현금 흐름 헤지 - 공정 가치 변동의 유효 부분 | - | - | - | 0.7 | - | - | 0.7 | |
Cash flow hedge - reclassification to profit or loss upon discontinuation of hedge accounting | - | - | - | 2.8 | - | - | 2.8 | |
외국법인 환산순환차손 | - | - | - | - | (1.3) | - | (1.3) | |
당해 년도 총 포괄 이익 | - | - | - | 3.9 | (1.3) | 30.8 | 33.4 | |
소유자와의 거래: |
| |||||||
자사주 매입 | 11 | - | (11.9) | - | - | - | - | (11.9) |
배당 | 11 | - | - | - | - | - | (32.2) | (32.2) |
주식선택권의 부여 | 12 | - | 17.3 | - | - | - | (17.3) | - |
주식기준보상수수료 | 12 | - | - | - | - | - | 19.4 | 19.4 |
주식기준보상세 | - | - | - | - | - | 0.8 | 0.8 | |
31 년 2023 월 XNUMX 일 잔액 |
| 0.2 | (65.4) | (44.3) | - | (2.0) | 169.3 | 57.8 |
연결 현금 흐름표
| 연말 31 12월 2023
| 연말 31 12월 2022 재 작성1 | |
영업 활동으로 인한 현금 흐름 | 노트 | £ m | £ m |
올해의 이익 | 30.8 | 30.5 | |
다음에 대한 조정 : | |||
감가 상각 | 6.2 | 6.4 | |
상각 | 9 | 10.6 | 10.1 |
다른 수입 | (0.6) | - | |
순 금융 비용 | 7 | 32.2 | 17.6 |
당기손익으로 인식되는 과세 | 10.7 | 7.9 | |
주식기준보상수수료 | 12 | 19.4 | 4.1 |
매출채권 및 기타채권 증가 | (6.5) | (9.2) | |
(감소)/매매대금 및 기타채무의 증가 | (1.1) | 17.2 | |
장단기파생상품의 재평가 | (0.8) | 0.6 | |
충당금 증가 | 0.1 | 0.2 | |
운영에서 발생하는 현금 |
| 101.0 | 85.4 |
이자 지급 | (23.0) | (14.0) | |
납부 한 소득세 | (12.0) | (9.5) | |
조건부 대가 지급 | 14 | (0.2) | - |
영업 활동으로 인한 총 현금 흐름 |
| 65.8 | 61.9 |
투자 활동으로 인한 현금 흐름 | |||
취득 | 14 | - | (33.6) |
대출금 상환으로 받은 현금 | 15 | - | 0.9 |
부동산, 플랜트 및 장비 구매 | (0.9) | (1.0) | |
무형 자산 매입 | 9 | (3.3) | (1.7) |
투자 활동에 사용된 총 현금 흐름 |
| (4.2) | (35.4) |
금융 활동으로 인한 현금 흐름 |
|
| |
차입금 상환 | 10 | (25.0) | (2.5) |
차입금 | 10 | - | 84.5 |
대출 재융자 수수료 | 10 | - | (0.7) |
자기주식취득 | 11 | (11.9) | (66.6) |
리스 지불의 주요 요소 | 10 | (5.4) | (5.9) |
배당금 지급 | 11 | (32.2) | (23.6) |
재무 활동에 사용된 총 현금 흐름 |
| (74.5) | (14.8) |
현금 및 현금 등가물 순 (감소) / 증가 |
| (12.9) | 11.7 |
연초 현금 및 현금 등가물 | 34.0 | 22.6 | |
현금및현금성자산에 대한 통화환산의 영향 | (1.3) | (0.3) | |
연말 현금 및 현금 등가물 |
| 19.8 | 34.0 |
1 The comparative year's cash flows have been restated as explained in the 2022 restatement section of note 1.
연결재무제표에 대한 주석
1. 일반정보
작업의 성격
GlobalData Plc와 그 자회사('그룹'으로 통칭)의 주요 활동은 여러 부문의 고객에게 고품질 독점 데이터, 분석 및 통찰력의 형태로 비즈니스 정보를 제공하는 것입니다.
GlobalData Plc('회사')는 영국(잉글랜드 및 웨일스)에서 설립되고 대체 투자 시장(AIM)에 상장된 회사이므로 공개적으로 소유하고 주식으로 제한됩니다. 회사의 등록 사무소는 John Carpenter House, John Carpenter Street, London, EC4Y 0AN입니다. 회사의 등록번호는 03925319입니다.
준비의 기초
요약재무제표는 공정가치로 측정되는 파생금융상품을 제외하고는 역사적원가를 기준으로 작성되었습니다. 요약재무제표에 포함된 정보는 영국에서 채택된 국제회계기준과 2006년 기업법 및 IASB에서 발행한 국제재무보고기준의 요구사항에 따라 작성되었지만, 이 공시 자체에는 충분한 정보가 포함되어 있지 않습니다. 영국이 채택한 국제 회계 기준을 준수하기 위한 정보. 31년 2023월 31일 종료 연도의 요약 재무제표는 2023년 XNUMX월 XNUMX일 종료 연도에 대한 GlobalData Plc의 연례 보고서 및 계정의 회계 정책 섹션에 명시된 재무 회계 정책에 따라 작성되었습니다. 이 요약 재무제표는 다음과 같습니다. 파운드 스털링(£)으로 표시됩니다.
31년 2023월 434일에 종료된 연도의 재무 정보는 2006년 회사법 31조에 정의된 법정 계정을 구성하지 않습니다. 2023년 31월 2023일에 종료된 연도의 법정 계정 사본은 적시에 회사 등록관에게 전달됩니다. . 498년 2006월 XNUMX일에 종료된 연도의 전체 재무제표에 대한 독립 감사인의 보고서는 부적격했으며 회사법 XNUMX의 섹션 XNUMX에 따른 문제 단락이나 진술을 강조하지 않았습니다.
기후변화에 대한 고려
In preparing the financial statements, management have considered the impact of climate change, particularly in the context of the risks identified in the Non-Financial and Sustainability Information Statement within the Group's Annual Report and Accounts for the year ended 31 December 2023. In particular, management considered the impact of climate change in respect of the following areas of accounting judgement or estimate:
· the assessment of goodwill, other intangibles and tangible fixed assets;
· the assessment of impairment of financial assets;
· our consideration of going concern and viability;
· the useful economic lives of assets; and
· the preparation of budgets and forecasts.
As a result of these considerations, no material climate change related impact was identified. Management are however aware of the changing nature of the risks associated with climate change and will regularly reassess these against the judgements and estimates made in preparing the Group's financial statements.
중요한 회계 추정 및 판단
연결실체는 미래에 대하여 추정 및 가정을 하고 있습니다. 추정 및 판단은 역사적 경험 및 상황에서 합리적이라고 생각되는 미래 사건에 대한 기대를 포함하여 기타 요소를 기반으로 지속적으로 평가됩니다.
향후 실제 경험은 이러한 추정 및 가정과 다를 수 있습니다. 다음 회계연도에 자산과 부채의 장부금액에 중대한 조정을 초래할 수 있는 상당한 위험이 있는 추정과 가정은 아래에서 자세히 논의됩니다. 기후 관련 위험은 재무제표에 중요한 영향을 미치지 않았습니다.
추정 불확실성의 주요 원인
영업권 및 기타 무형 자산의 운반 가치
The carrying value of goodwill and other intangibles is assessed annually to ensure that there is no impairment of these assets. Performing this assessment requires management to estimate future cash flows to be generated by the related cash-generating unit (CGU), which entails making judgements including the expected rate of growth of sales, margins expected to be achieved, the level of future capital expenditure required to support these outcomes and the appropriate discount rate to apply when valuing future cash flows. See note 9 for further details on intangibles and goodwill.
경영진은 각 현금창출단위에 대한 다양한 미래 거래 및 경제 시나리오에서 발생하는 주요 손상 테스트 가정의 영향을 고려하여 민감도 분석을 수행했습니다. 그룹 내에서 장애가 발생하기 전에 다음과 같은 개별 시나리오가 발생해야 합니다.
현금창출단위 | 수익 증가율 감소* | 할인율 상승 * |
데이터, 분석 및 인사이트 | (17.8의 %) | 32.8% |
미디어 비즈니스 통찰력("MBI") | (2.3의 %) | 3.9% |
*퍼센트 포인트
No indication of impairment was noted from Management's review; there is headroom in each CGU. Management acknowledges the sensitivity of the revenue growth and discount rate assumptions applied to the MBI CGU; however, Management is comfortable with these assumptions and will continue to monitor performance regularly for any indicators of future impairment loss.
Management recognises that the 2% cost growth assumption is lower than the current rate of inflation; however, the Group operates a focused approach to cost management, including mitigating the impact of inflation through advancements in technology and efficiency savings and has a strong track record of achieving this. Therefore, Management considers the assumption to be reasonable.
Management have modelled a reasonably possible scenario in which revenue growth in each CGU is 3.0% lower than the assumptions used within the impairment review. In this scenario there continues to be no indication of impairment within the Data, Analytics and Insights CGU. Within the MBI CGU, given the assumed revenue growth rate within the impairment review was 3.0%, this results in a 0.0% growth rate within the modelled scenario. In this scenario, an impairment of £3.1m would be recognised. Management recognises that whilst this scenario is plausible, it is highly unlikely. Additionally, in a scenario in which revenue growth is lower than expectation, cost mitigations could be implemented to limit the income statement impact of the revenue decline.
중요한 회계 판단
Accounting judgements in respect of the Inflexion transaction
On 21 December 2023, the Group announced that it had exchanged on a transaction to sell 40% of the Group's Healthcare business to Inflexion. Management have assessed the accounting implications arising from the transaction for the year ended 31 December 2023, taking into consideration the specific details set out in both the Share Option Agreement and Co-Investment Agreement. The most significant judgements included:
· Assessment of Control - Management considered the requirements of the applicable accounting standards, specifically 'IFRS 10 - Consolidated Financial Statements' and concluded that GlobalData Plc will have control of the Healthcare business, the results of which will therefore continue to be fully consolidated into the results of the GlobalData Plc Group from the date of completion. As at the same date, the Group will recognise a non-controlling interest within equity in the Group's Statement of Financial Position.
· Put and Call Options - At the point at which all of the Conditions Precedent of the investment agreement with Inflexion have been fulfilled, the Group or Inflexion can exercise an option to sell (put option) / buy (call option) the 40% shareholding in the Group's Healthcare business, following which the transaction will complete. Management have assessed that the put and call options meet the definition of a derivative as per 'IFRS 9 - Financial Instruments', and as such the options are measured at fair value and any movement in fair value will be recognised in the Income Statement. Management have measured the fair value of the options as at 31 December 2023 to be £nil.
· Completion date - Management have considered the Conditions Precedent set out within the Share Option Agreement, noting that the Conditions, some of which are outside of the control of the Group, must be fulfilled before the Put and Call Options can be exercised. As such, Management have concluded that the completion date will be the point at which the Options are exercised and as at 31 December 2023 the definition of a financial asset in accordance with IAS 32 has not been met. The Group does not have a virtually certain right to receive the cash proceeds from Inflexion and hence no receivable has been recognised within the Statement of Financial Position.
· Transaction Fees - Legal and professional fees incurred in relation to the transaction are recognised as a prepayment on the Group's Statement of Financial Position as at 31 December 2023, representing incremental costs that are related directly to a probable future equity transaction. The costs will be transferred to equity when the equity transaction is recognised (creation of the non-controlling interest), or in the event that the put and call option is not exercised, the costs will be recognised in the Income Statement at the point that the transaction is no longer expected to complete.
· Debt and Hedge Accounting - At completion of the transaction, the Group will repay in full the outstanding term loan and RCF from the disposal proceeds in accordance with the mandatory prepayment clause of the Facilities Agreement. In accordance with the requirements of 'IFRS 9 - Financial Instruments' Management have updated the expected cash payment profile for the term loan within the recalculation of the carrying amount of the cost of the liability as at 21 December 2023, to reflect full settlement, noting that IFRS 9 specifies estimates of payments. By discounting the payments at the effective interest rate ('EIR') of 9.62%, being the EIR at the time of exchange, a cost of £3.4m is included in interest in the income statement. As of 21 December 2023, the hedged item (i.e. the future interest costs on the term loan) are no longer highly probable to occur and hence hedge accounting has been discontinued in accordance with IFRS 9.
현금창출단위의 식별
IAS36 'Impairment of Assets' requires that assets be carried on the statement of financial position at no more than their recoverable amount. An asset or cash-generating unit (CGU) is the smallest identifiable group of assets that generates cash inflows and is impaired when its carrying amount exceeds its recoverable amount. As at the date of the impairment review (30 September 2023), Management made the judgement that the Group had two CGUs, being Data, Analytics and Insights and MBI.
Management is of the opinion that since acquisition and through being integrated and further developed within the Group, the acquired intangible assets of the Group all contribute to generating cash inflows for the wider business, covering all subject matter areas. All subject matters are accessible through the single operating platform (One Platform), and all products include access to a thin layer of information spanning across all markets and subjects. This represents the Group's main CGU, named 'Data, Analytics and Insights'. The Group's recent acquisitions of LMC (2021) and TS Lombard (2022) have been fully integrated into this CGU and therefore formed part of the Data, Analytics and Insights CGU at the time of impairment review (they were identified as individual CGUs in the prior year). In making this judgement Management has determined that the assets acquired as part of the acquisitions of LMC and TS Lombard are no longer generating cash flows that are separately identifiable. Management therefore concluded that the level of consolidation and integration does not make it possible for LMC or TS Lombard to meet the definition of a separately identifiable CGU as required by IAS36.
Management have concluded that the recent acquisition of MBI (acquired during 2022) remains a separate CGU as the product is inherently different to the Groups' main offering, and the brand, strategy and management of the business is separate from the rest of the Group. As a result of these conclusions, as at the date of the impairment review (30 September 2023), the Group had two CGUs.
Following the Group's reorganisation at the beginning of FY24 to create three new customer-focused business divisions (being Healthcare, Consumer and Technology), an assessment of the Group's CGUs will be performed ahead of the annual impairment review (30 September).
관심가는
The Group meets its day-to-day working capital requirements through free cash flow. The Group has closing cash of £19.8m as at 31 December 2023 and net bank debt of £243.9m (31 December 2022: cash of £34.0m and net bank debt of £249.6m), being cash and cash equivalents less short and long-term borrowings, excluding lease liabilities. The Group has an outstanding term loan of £265.0m (2022: £290.0m) which is syndicated with 12 lenders. As at 31 December 2023, the Group had undrawn RCF of £120.0m which is syndicated with 13 lenders. During January 2024, £20.0m of the RCF was drawn down to support a share buy-back. The Group's banking facilities are in place until August 2025, however the Group intends to fully repay the term loan upon completion of the investment agreement with Inflexion. In the unanticipated event that completion does not occur, the Group will be required to renew or extend its financing arrangements. The Group has generated £101.0m in cash from operations during 2023 (2022: £85.4m). Based on cash flow projections the Group considers the existing financing facilities to be adequate to meet short-term commitments.
금융 시설은 분기별로 측정되는 부채 약정과 함께 발행되었습니다. 31년 2023월 12일에 종료된 연도에는 약정 위반이 없었습니다. 경영진은 예상 현금 흐름을 검토했으며 향후 XNUMX개월 동안 위반이 있을 것이라는 징후는 없습니다.
The Directors have a reasonable expectation that there are no material uncertainties that cast significant doubt about the Group's ability to continue in operation and meet its liabilities as they fall due for the foreseeable future, being a period of at least 12 months from the date of approval of the financial statements. The Directors have modelled a number of worst-case scenarios to consider their potential impact on the Group's results, cash flow and loan covenant forecast. Key assumptions built into the scenarios focus on revenue and cost growth. In addition to performing scenario planning, the Directors have also conducted stress testing of the Group's forecasts and, taking into account reasonable downside sensitivities (acknowledging that such risks and uncertainties exist), the Directors are satisfied that the business is expected to operate within its facilities. The plausible downside scenarios modelled were as follows: (i) subscription sales in 2024 being approximately 10% lower than expectation (ii) cost growth in line with the current UK rate of inflation and (iii) both scenarios combined. There remains headroom on the covenants under each scenario and cash remained in excess of £16.3m in all months.
정상적인 비즈니스 관행을 통해 우리는 대출 기관과 정기적으로 소통하고 있으며 그들이 가까운 장래에 우리를 계속 지원할 수 있는 위치에 있다는 것에 만족합니다.
따라서 이사들은 자금 조달 준비와 함께 충분한 현금 준비금 및 운전 자본을 갖춘 강력한 대차대조표가 충분한 유동성을 제공한다고 생각합니다. 따라서 이사들은 계속기업 기준으로 재무제표를 작성했습니다.
2022 restatement
Following a Financial Reporting Council ("FRC") review of the consolidated financial statements for the year ended 31 December 2022, the Group has restated the Consolidated Statement of Cash Flows to present the settlement of the previous term loan and Revolving Credit Facilities ("RCF"), the proceeds from the new term loan and the loan fees incurred on the new facility as a net financing cash inflow of £53.5m within proceeds from borrowings. The amounts in respect of this transaction were previously presented gross, this restatement reflects that the cash inflow actually occurred on a net basis. The £53.5m comprises the following individual amounts:
£ m | |
Repayment of the old term loan and RCF | (229.2) |
Loan fees incurred on the new facility | (7.3) |
Drawdown of the new term loan | 290.0 |
차입금 | 53.5 |
The proceeds from borrowings presented in the Consolidated Statement of Cash Flows also includes a balance of £31.0m in respect of drawdowns on the old RCF in the six months to June 2022 hence giving a total balance of £84.5m.
The impact of the restatement is set out below:
금융 활동으로 인한 현금 흐름 : | 2022 | 2022 | 2022 |
대출 정산 | (229.2) | - | 229.2 |
차입금 | 321.0 | 84.5 | (236.5) |
대출 재융자 수수료 | (8.0) | (0.7) | 7.3 |
83.8 | 83.8 | - |
The changes have a £nil net impact on the Group's financial position and performance for the year ended 31 December 2022.
2. 회계정책
These condensed financial statements have been prepared based on the accounting policies detailed in the Group's financial statements for the year ended 31 December 2023 and is consistent with the policies applied in the previous year, except for the following new standards The new standards which are effective during the year (and have not had any material impact on the disclosures or on the amounts reported in these financial statements) are:
· IFRS 17: Insurance contracts;
· Amendments to IAS 1: Presentation of Financial Statements and IFRS Practice Statement 2: Making Materiality Judgements - Disclosure of Accounting Policies;
· Amendments to IAS 12: Income Taxes - Deferred Tax related to Assets and Liabilities arising from a Single Transaction;
· Amendments to IAS 12: Income Taxes - International Tax Reform - Pillar Two Model Rules; and
· Amendments to IAS 8: Accounting Polices, Changes in Accounting Estimates and Errors - Definition of Accounting Estimates.
사전비법정 대체 성과 측정의 발령
이사들은 조정된 EBITDA, 조정된 EBITDA 마진, 조정된 세전 이익, 조정된 세후 이익 및 조정된 주당 이익이 그룹의 운영 성과에 대한 추가적인 유용한 정보를 주주들에게 제공한다고 믿고 있으며, 우리는 이러한 측정을 사용하여 그룹의 결과를 검토합니다. 내부적으로. '조정'이라는 용어는 IFRS에서 정의된 용어가 아니므로 다른 회사에서 보고한 유사한 제목의 이익 측정치와 비교할 수 없습니다. 이는 IFRS의 이익 측정을 대체하거나 더 우수하게 만들 의도가 없습니다.
다음과 관련하여 조정됩니다.
주식기준보상 및 관련 비용 | 주식기준보상비용은 비현금 비용이고 보상이 주식결제형이므로 조정 EBITDA에서 제외됩니다. |
구조조정, M&A(조건부 대가 포함) 및 재융자 비용 | 그룹은 항목의 성격이나 크기가 그룹의 운영 성과와 관련이 없고 기본 결과의 비교를 허용하는 경우 조정 EBITDA에서 이러한 비용을 제외합니다. |
취득한 무형자산의 상각 및 손상 | The amortisation charge for those intangible assets recognised on business combinations is excluded from Adjusted EBITDA since they are non-cash charges arising from historical investment activities. Any impairment charges recognised in relation to these intangible assets are also excluded from Adjusted EBITDA. This is a common adjustment made by acquisitive information service businesses and is therefore consistent with peers. Revenues associated with acquisitions, in the year of acquisition, are excluded from the calculation of underlying revenue. |
장단기파생상품의 재평가 | 손익은 현금으로 실현될 때 조정 EBITDA 내에서 인식되므로 조정 EBITDA를 사업의 현금 실적과 더 잘 일치시키는 환율 변동으로 인해 발생하는 비현금 움직임을 제외합니다. |
미실현영업외환손익 | |
금리스왑 재평가 | Gains and losses on the revaluation of the interest rate swap are excluded from Adjusted profit before tax which better aligns with the cash performance of the business. |
3. 부문별 분석
GlobalData Plc와 그 자회사('그룹'으로 통칭)의 주요 활동은 여러 부문의 고객에게 고품질 독점 데이터, 분석 및 통찰력의 형태로 비즈니스 정보를 제공하는 것입니다.
IFRS8 "영업 부문"은 재무제표에 표시되는 부문 정보가 최고 운영 의사 결정자가 비즈니스 성과를 평가하고 자원 할당 방법을 결정하기 위해 내부적으로 사용하도록 요구합니다. 그룹은 CEO를 최고 운영 의사 결정자로 식별했습니다.
그룹은 공통 분류, 공유 개발 리소스 및 새로운 데이터 과학 기술로 뒷받침되는 중앙 집중식 운영 모델 및 단일 제품 플랫폼(One Platform)을 유지합니다. GlobalData 비즈니스 모델의 기본 원칙은 고객에게 컨설팅, 단일 사본 보고서 및 이벤트와 같은 보조 서비스를 제공하여 독점 데이터, 분석 및 통찰력 플랫폼에 대한 구독 액세스를 제공하는 것입니다. 그룹에서 판매하는 대부분의 데이터는 그룹 전체에 대한 데이터를 생성하는 중앙 연구 팀에서 생성합니다. 중앙 리서치 팀은 그룹 최고 경영자에게 보고하는 인도 사업부의 전무 이사인 한 명의 중앙 개인에게 보고합니다. 따라서 '데이터, 분석 및 통찰력'은 그룹의 운영 부문으로 간주됩니다.
그룹 손익은 매월 CEO에게 보고되며 이자, 세금, 감가상각비, 상각비, 중앙 간접비 및 기타 조정 전 수입으로 구성됩니다. CEO는 또한 운영 부문 내 수익을 모니터링합니다.
연결실체는 다음과 같은 이유로 단일 영업부문을 사용하는 것이 적절하다고 생각합니다.
· 그룹 수준에서 손익을 검토하는 최고 경영자
· 중앙 집중식 운영 모델 활용
· 포트폴리오 비즈니스가 아닌 통합 솔루션 기반 비즈니스 그리고
· 그룹의 M&A 전략은 One Platform 내에서 완전히 통합하는 것입니다.
Following the Group's reorganisation at the beginning of FY24 to create three new customer-focused business divisions (being Healthcare, Consumer and Technology), an assessment of the Group's reportable segments will be performed during H1 2024.
계속 운영에서 발생하는 세전 이익에 대한 조정 EBITDA의 조정은 다음과 같습니다.
연말 31 12월 2023 £ m | 연말 31 12월 2022 £ m | |
조정 EBITDA | 110.8 | 86.4 |
구조 조정 비용 | (1.7) | (0.6) |
M&A 비용 | (0.4) | (2.9) |
우발적 고려 | (0.9) | (1.0) |
재융자 비용 | - | (1.9) |
주식기준보상수수료 | (19.4) | (4.1) |
주식기준보상제도와 관련된 비용 | (0.2) | (0.9) |
Revaluation gain/(loss) on short and long-term derivatives | 0.8 | (0.6) |
Unrealised operating foreign exchange gains/(losses) | 1.5 | (1.9) |
취득한 무형자산의 상각 | (9.0) | (9.1) |
감가 상각 | (6.2) | (6.4) |
상각(취득한 무형자산 상각 제외) | (1.6) | (1.0) |
금융 비용 | (32.2) | (17.6) |
과세 전 소득 | 41.5 | 38.4 |
지리적 분석
당사의 주요 지리적 시장은 팀 위치에 따라 유럽, 미국 및 아시아 태평양으로 구성된 글로벌 영업 팀이 서비스를 제공합니다. 아래의 세분화된 수익은 그룹을 구성하는 팀 구조가 아닌 고객의 지리적 위치에서 파생됩니다.
지속적인 운영에서
31년 2023월 XNUMX일 종료 | UK | 유럽 | 미주1 | 아시아 태평양 | MENA2 | 세계의 나머지 | 금액 |
| £ m | £ m | £ m | £ m | £ m | £ m | £ m |
외부 고객으로부터의 수익 | 43.4 | 73.9 | 99.1 | 27.9 | 20.4 | 8.4 | 273.1 |
31년 2022월 XNUMX일 종료 | UK | 유럽 | 미주1 | 아시아 태평양 | MENA2 | 세계의 나머지 | 금액 |
| £ m | £ m | £ m | £ m | £ m | £ m | £ m |
외부 고객으로부터의 수익 | 36.0 | 64.7 | 91.4 | 27.2 | 16.6 | 7.3 | 243.2 |
1. Americas includes revenue from the United States of America of £95.8m (2022: £86.7m)
2. 중동 및 북아프리카
미국과 캐나다에서 보유하고 있는 무형 자산은 £35.1m(2022: £35.9m)이며, 이 중 £31.6m은 영업권과 관련이 있습니다(2022: £31.6m). UAE에서 보유하고 있는 무형 자산은 £12.1m(2022년: £12.8m)이며, 그 중 £11.4m은 영업권과 관련이 있습니다(2022년: £11.4m). 기타 모든 비유동 자산은 영국에 보유됩니다. 가장 큰 고객은 그룹 통합 수익의 2% 미만을 차지했습니다.
4. 수익
그룹은 반복 구독과 같은 일정 기간 동안 제공되는 서비스와 보고서, 이벤트 및 맞춤형 연구와 같이 특정 시점에 제공할 수 있는 기타 서비스에서 수익을 창출합니다.
온라인 서비스, 데이터 및 분석에 대한 구독 수입(일반적으로 12개월)은 일반적으로 서비스 시작 시 청구되며 따라서 재무상태표에서 계약 부채인 "이연 수익"으로 인식됩니다. 계약기간에 걸쳐 이행의무를 균등하게 이행하므로 계약기간에 걸쳐 균등하게 수익을 인식합니다.
특정 시점에 제공된 서비스에 대한 수익은 정적 보고서의 전달 또는 이벤트의 전달과 같은 계약상 의무가 충족된 시점에 인식됩니다. 이러한 유형의 계약에 대한 의무는 별개의 의무이며 일단 충족되면 계약 조건에 따라 그룹 수행 의무를 충족합니다.
여전히 수행의무가 있고 지급을 받았거나 계약상 만기가 도래한 송장에 기재된 계약금액은 재무상태표일 현재 이연수익으로 인식됩니다. 연결실체는 일반적으로 각 계약의 시작 시점에 현금을 결제받으며, 표준 조건은 XNUMX일입니다. 마찬가지로 연결실체는 대가를 받거나 계약상 지급기일 이전에 수행의무를 이행한 경우 재무상태표의 미수수익 범위에서 계약자산을 인식합니다.
연결손익계산서에 인식된 수익
| 연결재무상태표에 인식된 이연수익 | |||
| 31년 2023월 XNUMX일 종료 | 31년 2022월 XNUMX일 종료 | 31 년 2023 월 XNUMX 일 기준 | 31 년 2022 월 XNUMX 일 기준 |
| £ m | £ m | £ m | £ m |
이전된 서비스: |
|
|
|
|
일정 기간 동안 | 215.3 | 196.5 | 89.5 | 91.6 |
어느 시점에서 | 57.8 | 46.7 | 15.1 | 12.4 |
금액 | 273.1 | 243.2 | 104.6 | 104.0 |
As subscriptions are typically for periods of 12 months the majority of deferred revenue held at 31 December will be recognised in the income statement in the following year. As at 31 December 2023, £2.0m (2022: £1.1m) of the deferred revenue balance will be recognised beyond the next 12 months. In the year ended 31 December 2023 the Group recognised revenue of £102.9m (2022: £81.0m) that was included in the deferred revenue balance at the beginning of the period. The opening deferred revenue balance as at 1 January 2022 was £81.4m.
31년 2023월 104.6일 현재 수익을 이행하기 위한 이연 수익 내 취소 불가능한 총 의무는 £2022m(104.0년: £135.2m)에 달했습니다. 같은 날짜와 마찬가지로 수익을 이행하기 위한 송장된 선도 수익 내 취소 불가능한 총 의무는 £2022m(133.5년: £XNUMXm)에 달했습니다.
그룹이 구독 및 맞춤형 연구와 같은 그룹의 서비스 범위와 관련된 거래를 체결하는 경우 계약의 총 거래 가격은 상대적 독립 판매 가격을 기준으로 다양한 이행 의무에 할당됩니다.
5. 영업이익
영업 이익은 계속 운영과 관련된 다음 비용을 공제한 후 표시됩니다.
| 연말 31 12월 2023 | 연말 31 12월 2022 | |
|
| £ m | £ m |
매출원가 | 132.0 | 125.7 | |
관리 비용 | 65.7 | 60.9 | |
|
| 197.7 | 186.6 |
매출채권손실 |
| 2.3 | 0.7 |
총 운영 비용 |
| 200.0 | 187.3 |
Cost of sales includes all directly attributable costs of sale including product, consulting and sales costs. Administrative costs includes all other costs of operations.
6. 항목 조정
|
연말 31 12월 2023 |
연말 31 12월 2022 | |
|
| £ m | £ m |
주식기준보상수수료 | 19.4 | 4.1 | |
취득한 무형자산의 상각 | 9.0 | 9.1 | |
구조 조정 비용 | 1.7 | 0.6 | |
우발적 고려 | 0.9 | 1.0 | |
M&A 비용 | 0.4 | 2.9 | |
주식기준보상제도와 관련된 비용 | 0.2 | 0.9 | |
재융자 비용 | - | 1.9 | |
Revaluation (gain)/loss on short and long-term derivatives | (0.8) | 0.6 | |
미실현 영업외환(이익)/손실 | (1.5) | 1.9 | |
총 조정 항목 |
| 29.3 | 23.0 |
조정된 사항은 다음과 같습니다.
· 주식 기준 지급 비용은 s와 관련이 있습니다.hare-based compensation plans (detailed in note 12) under which the entity receives services from employees as consideration for equity instruments (options) of the Group. The fair value of the employee services received in exchange for the grant of the options and awards is recognised as an expense in the income statement. The total amount to be expensed is determined by reference to the fair value of the options granted. The original fair value on grant date is charged to the income statement based upon the Monte-Carlo method. Following modification on 30 November 2022, an additional charge for the beneficial modification was determined by the Black-Scholes method.
· The amortisation charge for those intangible assets recognised on business combinations.
· Restructuring costs relate to redundancy payments and professional fees incurred in relation to group reorganisation projects.
· 조건부 고려 금액은 2023년에서 2025년 사이에 MBI 및 TS Lombard의 이전 소유주에 대한 지불과 관련됩니다. 이는 지불 시점에 그룹의 직원으로 남아 있는 이전 소유주에 따라 달라지기 때문에 보수 비용으로 처리되었습니다.
· The M&A costs consist of professional fees incurred in performing due diligence relating to potential acquisition targets and redundancy costs in relation to group integration projects.
· Costs relating to share-based payments scheme consist of employer taxes borne as a result of the vesting of options within the final tranche of Scheme 1 during the year, and professional fees incurred in advice obtained relating to the consolidation and subdivision of share capital.
· Refinancing costs in the prior year consisted of legal fees incurred in relation to (i) the extension of the previously held term loan and RCF by one year (completed during June 2022) and (ii) the arrangement of the new loan facility which was drawn down upon during August 2022.
· The revaluation of short and long-term derivatives relates to movement in the fair value of the short and long-term derivatives.
· Unrealised operating foreign exchange gains and losses relate to non-cash exchange losses and gains made on operating items.
7. Net finance costs
31월 XNUMX일 종료 2023 | 31월 XNUMX일 종료 2022 | |
| £ m | £ m |
대출이자비용 | 28.6 | 16.4 |
임대이자비용 | 1.1 | 1.3 |
금리스왑 재평가 | 2.8 | - |
기타이자 비용 | 0.1 | 0.1 |
기타이자 소득 | (0.4) | (0.2) |
32.2 | 17.6 |
Loan interest cost includes non-cash interest relating to financial liabilities measured at amortised cost of £5.1m (2022: 2.1m). The increased charge in the year reflects the change in anticipated cash flows on the term loan. The Group intends to fully repay the loan upon completion of the investment agreement with Inflexion. As a result of the change in anticipated cash flows, the Group recognised a non-cash interest expense of £3.4m in accordance with IFRS 9, which requires that any revisions to the estimate of payments, should be adjusted against the amortised cost of a financial liability by recalculating the present value of the estimated future cash flows, discounted at the financial instrument's original effective interest rate.
The £2.8m charge in respect of the revaluation of the interest rate swap reflects that the hedged items (future interest repayments) are no longer probable or expected to occur and as such hedge accounting has been discontinued. The cumulative loss balance held in the cash flow hedge reserve of £2.8m was transferred to the income statement at the end of the year (2022: £3.9m loss recognised through the statement of other comprehensive income).
8. 주당순이익
기본주당이익의 산정은 모회사의 보통주에 귀속되는 이익을 당해 기간의 가중평균 발행주식수로 나눈 값을 기준으로 합니다. 연결실체는 또한 주식선택권제도를 시행하고 있으므로 연결실체는 이러한 주식선택권의 희석효과를 계산하였습니다.
25년 2023월 118,303,869일에 실시된 자본 재편성 행사에 따라 회사의 기존 발행 보통주 0.000714주(주당 명목 가치 £1)가 기존 보통주 14주당 연결주 100주를 기준으로 통합된 후 1주를 기준으로 세분화되었습니다. 연결주식 845,027,700주당 신보통주로 한다. 조직 개편 후 발행 보통주 0.0001주(주당 명목 가치 £26)가 AIM에 승인되어 2023년 XNUMX월 XNUMX일에 거래를 시작했습니다.
The prior year comparatives have been restated to reflect the impact of the share-split on basic and diluted earnings per share in accordance with IAS 33: Earnings Per Share.
The earnings per share presented below is based upon the post-reorganisation share structure:
연말 31 12월 2023
| 연말 31 12월 2022 재 작성 | ||
계속 영업에서 주주에게 귀속되는 주당 수익: |
|
| |
Basic | |||
모회사의 일반 주주에게 귀속되는 기간 동안의 이익(백만 파운드) | 30.8 | 30.5 | |
가중 평균 주식 수(no' m) | 807.1 | 805.0 | |
기본 주당순이익(펜스) | 3.8 | 3.8 | |
희석 | |||
모회사의 일반 주주에게 귀속되는 기간 동안의 이익(백만 파운드) | 30.8 | 30.5 | |
가중 평균 주식 수(no' m) | 818.2 | 819.3 | |
희석 주당 순이익(펜스) | 3.8 | 3.7 |
기본 가중평균 주식수를 희석 가중평균 주식수로 조정:
| 연말 31 12월 2023
안돼 | 연말 31 12월 2022 재 작성 안돼 | |
기본 가중 평균 주식 수, 재무 준비금 보유 주식 순 | 807.1 | 805.0 | |
Dilutive share options in issue - scheme 1 | 4.5 | 14.3 | |
Dilutive share options in issue - scheme 2 | 6.6 | - | |
희석가중평균 번호 주식의 |
| 818.2 | 819.3 |
The diluted earnings per share calculation does not include performance-related share options where the performance criteria had not been met in the period, in accordance with IAS 33. The table below shows the number of share options which could become dilutive should future performance criteria be met. It excludes 6,624,997 options which are anticipated to vest in the year ended 31 December 2024 as these are included in the diluted weighted average number of shares calculation above given the performance criteria for these options has been met.
잠재적 희석주 |
| 2024 | 2025 | 2026 | 2027 | 금액 |
스케쥴 |
| 그렇지 않습니다. | 그렇지 않습니다. | 그렇지 않습니다. | 그렇지 않습니다. | 그렇지 않습니다. |
계획 2 | - | 6,624,997 | 6,624,997 | 6,624,997 | 19,874,991 | |
계획 4 | - | 1,964,276 | 3,928,552 | 13,749,935 | 19,642,763 | |
금액 |
| - | 8,589,273 | 10,553,549 | 20,374,932 | 39,517,754 |
9. 무형 자산
| AUC* | 소프트웨어 | 고객 관계 | 브랜드 | 지적재산권 및 데이터베이스 | 친선 | 금액 |
| £ m | £ m | £ m | £ m | £ m | £ m | £ m |
비용 |
|
|
|
|
|
|
|
1년 2022월 XNUMX일 현재 | - | 12.8 | 55.8 | 16.2 | 75.5 | 302.7 | 463.0 |
추가 사항: 사업 결합 | - | 0.9 | 9.5 | 10.0 | 2.4 | 19.2 | 42.0 |
추가 사항: 별도 획득 | - | 1.7 | - | - | - | - | 1.7 |
공정가치 조정 | - | - | - | - | - | 0.1 | 0.1 |
31 년 2022 월 XNUMX 일 기준 | - | 15.4 | 65.3 | 26.2 | 77.9 | 322.0 | 506.8 |
추가 사항: 별도 획득 | 0.2 | 3.0 | - | 0.1 | - | - | 3.3 |
31 년 2023 월 XNUMX 일 기준 | 0.2 | 18.4 | 65.3 | 26.3 | 77.9 | 322.0 | 510.1 |
|
| ||||||
상각 |
| ||||||
1년 2022월 XNUMX일 현재 | - | (11.0) | (32.6) | (11.3) | (49.5) | (10.9) | (115.3) |
추가 사항: 사업 결합 | - | (0.8) | - | - | (0.5) | - | (1.3) |
연도 요금 | - | (1.1) | (5.2) | (0.9) | (2.9) | - | (10.1) |
31 년 2022 월 XNUMX 일 기준 | - | (12.9) | (37.8) | (12.2) | (52.9) | (10.9) | (126.7) |
연도 요금 | - | (1.6) | (4.7) | (1.2) | (3.1) | - | (10.6) |
31 년 2023 월 XNUMX 일 기준 | - | (14.5) | (42.5) | (13.4) | (56.0) | (10.9) | (137.3) |
| |||||||
순 장부가 | |||||||
31 년 2023 월 XNUMX 일 기준 | 0.2 | 3.9 | 22.8 | 12.9 | 21.9 | 311.1 | 372.8 |
31 년 2022 월 XNUMX 일 기준 | - | 2.5 | 27.5 | 14.0 | 25.0 | 311.1 | 380.1 |
*AUC: Assets under construction which will be transferred to software post development.
10. Borrowings
| 31 12월 2023 £ m | 31 12월 2022 £ m | |||
단기리스부채 | 4.3 | 5.4 | |||
유동 부채 |
| 4.3 | 5.4 | ||
장기리스 부채 | 21.4 | 24.6 | |||
장기 차입금 | 263.7 | 283.6 | |||
비유동 부채 |
| 285.1 | 308.2 | ||
연결실체 차입금의 변동은 다음과 같이 구분할 수 있습니다.
|
| 단기 차입금 | 장기 차입금 | 단기리스부채2 | 장기리스 부채2 | 금액 |
|
| £ m | £ m | £ m | £ m | £ m |
1년 2022월 XNUMX일 현재 | 5.0 | 195.2 | 4.1 | 29.3 | 233.6 | |
현금 흐름: |
|
|
|
|
| |
- 반환 | (2.5) | - | (5.9) | - | (8.4) | |
- 수입 (다시 말함1) | - | 84.5 | - | - | 84.5 | |
- 대출 수수료 지불 (다시 말함1) | - | (0.7) | - | - | (0.7) | |
비현금: | ||||||
- 이자 비용 | - | 2.1 | - | - | 2.1 | |
- 임대 추가 | - | - | 0.6 | - | 0.6 | |
- 리스 부채3 | - | - | 1.5 | 0.4 | 1.9 | |
- 재분류 | (2.5) | 2.5 | 5.1 | (5.1) | - | |
31 년 2022 월 XNUMX 일 기준 | - | 283.6 | 5.4 | 24.6 | 313.6 | |
현금 흐름: |
| |||||
- 상환 | - | (25.0) | (5.4) | - | (30.4) | |
- 수익금 | - | - | - | - | - | |
- 대출 수수료 지불 | - | - | - | - | - | |
- 대출 정산 | - | - | - | - | - | |
비현금: |
| |||||
- 이자 비용 | - | 5.1 | - | - | 5.1 | |
- 임대 추가 | - | - | 1.4 | - | 1.4 | |
- 리스부채3 | - | - | 0.1 | (0.4) | (0.3) | |
- 재분류 | - | - | 2.8 | (2.8) | - | |
31 년 2023 월 XNUMX 일 기준 |
| - | 263.7 | 4.3 | 21.4 | 289.4 |
1 The comparative year's cash flows have been restated as explained in the 2022 restatement section of the Accounting Policies on page 28.
2 금액은 임대료 선불 및 발생액을 차감한 금액입니다.
3 리스 부채 발생 및 선불에 대한 리스 이자, 황폐화 및 움직임을 나타냅니다.
기간 대출 및 RCF
2022년 290.0월에 그룹은 M&A를 포함한 비즈니스의 장기적인 성장을 지원하기 위한 추가 자금을 그룹에 제공하기 위해 새로운 120.0년 부채 조달 시설을 완료했습니다. 부채 편익은 £2025m의 정기 대출과 £12m의 RCF로 구성됩니다. 새로운 시설은 13년 동안 운영되도록 마련되었습니다. 고정된 주기적인 자본 상환은 없으며 시설이 XNUMX년 XNUMX월에 만료되면 전체 잔액이 정산되어야 합니다. 기간 대출은 XNUMX개 대출 기관 간에 신디케이트되고 RCF는 XNUMX개 대출 기관 간에 신디케이트됩니다.
As at 31 December 2022, the Group had fully drawn down the term loan of £290.0m. On 3 April 2023, the Group voluntarily repaid £25.0m of the term loan, resulting in the current term loan drawdown on 31 December 2023 of £265.0m. As at 31 December 2023, the Group was yet to draw down the available RCF facility of £120.0m. During January 2024, £20.0m of the RCF was drawn down to support a share buy-back. In accordance with the provisions of IFRS9 (including offsetting of loan fees paid as part of the refinancing process), the term loan is held on the statement of financial position with a value of £263.7m (31 December 2022: £283.6m). The Group intends to fully repay the loan upon completion of the investment agreement with Inflexion. As a result of the change in anticipated cash flows, the Group recognised a non-cash interest expense of £3.4m in accordance with IFRS 9, which requires that any revisions to the estimate of payments, should be adjusted against the amortised cost of a financial liability by recalculating the present value of the estimated future cash flows, discounted at the financial instrument's original effective interest rate.
Interest is currently charged on the term loan at a rate of 3.0% over the Sterling Overnight Index Average rate (SONIA) and is payable at the end of each calendar quarter. The Group entered into an interest rate swap during October 2022, with an effective date of 30 September 2022, initially based on a notional amount of £290.0m, which matched against the initial term loan drawdown. The notional amount of the swap was amended to £265.0m on 3 April 2023 (the same date as the voluntary repayment noted above), which aligns to the current term loan draw down. The agreement is to swap, on a calendar quarter basis, SONIA for a fixed rate of 4.9125%.
11. Equity
주식 자본
승인, 할당, 호출 및 전액 지불:
31 12월 2023 | 31 12월 2022 | |||||
아니요1 | 총 주식의 비율 | £000s | 아니요1 | 총 주식의 비율 | £000s | |
| 재 작성 |
|
| |||
보통주 (£0.0001) | 845,028 | 99.99 | 84 | 845,028 | 99.99 | 84 |
각 £1.00의 이연주 | 100 | 0.01 | 100 | 100 | 0.01 | 100 |
총 승인, 할당, 호출 및 전액 지불 | 845,128 | 100.00 | 184 | 845,128 | 100.00 | 184 |
1아래에 설명된 대로 재구성 후 위치를 반영합니다.
25년 2023월 118,303,878일에 실시된 자본 재편성 행사에 따라 회사는 발행 보통주 수를 0.000714주(주당 명목 가치 £1)로 늘리기 위해 14개의 보통주를 발행했습니다. 이후 기존 보통주 100주당 연결주 1주를 기준으로 기존 보통주 전체를 연결하고, 연결 보통주 845,027,700주당 신주 0.0001주를 기준으로 세분화하였습니다. 조직 개편 후 발행 보통주 26주(주당 명목 가치 £2023)가 AIM에 승인되어 XNUMX년 XNUMX월 XNUMX일에 거래를 시작했습니다.
The prior year comparatives have been restated to reflect the impact of the share-split on basic and diluted earnings per share in accordance with IAS 33: Earnings Per Share.
구매 공유
해당 연도 동안 그룹의 Employee Benefit Trust는 총 7,862,788주(총 주식 자본의 0.9%에 해당)를 매입했으며, 각 주식의 명목 가치는 1/100입니다.th 펜스, 총 시장 가치 £11.9m. 매입한 주식은 회사의 종업원주식선택권에 따른 주식선택권 행사를 충족시키기 위한 목적으로 보유하게 됩니다.
한 해 동안 총 9,784,472주(총 주식 자본의 1.2%에 해당), 각 주식의 명목 가치는 1/100th 그룹의 Employee Benefit Trust가 보유한 펜스는 각주 1에 공시된 바와 같이 Scheme 17.3 주식 옵션의 최종 트랑슈(총 시장 가치 £12m)의 귀속 결과로 활용되었습니다.
최대 주식 수(각 액면가의 1/100)th Employee Benefit Trust(31년 2023월 39,921,579일 종료 연도 중 언제든지)가 보유한 4.7주(총 주식 자본의 XNUMX%)입니다.
The purchase of shares by the trust is to limit the eventual dilution to existing shareholders. As at 31 December 2023, no dilution is forecast until 2027.
조끼 일정 | 2024 번호 | 2025 번호 | 2026 번호 | 2027 번호 | 총 개수
|
계획 1* | 2,230,806 | 2,230,805 | - | - | 4,461,611 |
계획 2 | 6,624,997 | 6,624,997 | 6,624,997 | 6,624,997 | 26,499,988 |
계획 4 | - | 1,964,276 | 3,928,552 | 13,749,935 | 19,642,763 |
금액 | 8,855,803 | 10,820,078 | 10,553,549 | 20,374,932 | 50,604,362 |
신탁 보유 주식 | (8,855,803) | (10,820,078) | (10,553,549) | (7,656,129) | (37,885,559) |
순 희석 | - | - | - | 12,718,803 | 12,718,803 |
*The remaining share options in Scheme 1 can be exercised anytime until August 2033 and therefore for the purposes of this analysis we have assumed they will be exercised within the next two years.
자본 관리
그룹의 자본 관리 목표는 다음과 같습니다.
· 그룹이 계속 기업으로 존속할 수 있는 능력을 보장하기 위해 그리고
· 미래 성장 자금을 조달하고 주주에게 적절한 수익을 제공하며 적절한 경우 배당금을 분배합니다.
연결실체의 자본구조는 차입금(주석 10)과 현금및현금성자산을 포함한 순은행부채와 자본으로 구성되어 있습니다.
회사에는 두 종류의 주식이 있습니다. 보통주는 고정 수입에 대한 권리가 없으며 각 주식은 회사 총회에서 하나의 의결권을 갖습니다.
연기된 주식은 보유자에게 회사의 이익에 대한 배당, 분배 또는 기타 참여를 받을 권리를 부여하지 않습니다. 연기된 주식은 보유자가 통지를 받거나 회사의 모든 총회에 참석하고 발언하거나 투표할 수 있는 자격을 부여하지 않습니다. 청산 또는 기타 방식으로 자산을 분배할 때 부채를 상환한 후 남은 회사의 잉여 자산은 연기 주식 보유자에게 해당 주식에 대해 납입 또는 납입된 것으로 간주되는 명목 금액 및 프리미엄을 상환하는 데 우선 적용됩니다. 둘째, 그러한 자산의 잔액은 보통주 보유자가 각각 소유한 보통주에 대해 납입된 명목 금액에 비례하여 보통주 소유주에게 귀속되고 이들에게 분배됩니다.
보유 규모나 주식 양도에 대한 특별한 제한은 없으며, 정관의 일반 조항과 지배적인 법률에 의해 규율됩니다. 이사들은 증권 양도 또는 의결권에 대한 제한을 초래할 수 있는 회사 주식 보유자 간의 합의에 대해 알지 못합니다.
어느 누구도 회사의 주식 자본에 대한 특별한 통제권을 가지고 있지 않으며 모든 발행 주식은 완납되었습니다.
이사의 선임 및 교체에 관하여 회사는 정관, 회사법 및 관계법령에 따릅니다. 정관 자체는 주주의 특별 결의로 개정될 수 있습니다. 이사의 권한은 이사회 위임 사항에 설명되어 있으며 사본은 요청 시 제공됩니다.
배당
The final dividend for 2022 was 2.6 pence per share (restated) and was paid in April 2023. The total dividend for the current year is 4.6 pence per share, with an interim dividend of 1.4 pence per share paid on 6 October 2023 to shareholders on the register at the close of business on 8 September 2023, and a final dividend of 3.2 pence per share will be paid on 26 April 2024 to shareholders on the register at the close of business on 22 March 2024. The ex-dividend date will be on 21 March 2024.
재무 준비금
재무 준비금은 회사의 직원 주식 옵션 계획에 따른 주식 옵션 행사를 충족하기 위해 그룹의 직원 복지 신탁에서 보유한 주식의 비용을 나타냅니다.
현금 흐름 헤지 준비금
현금흐름위험회피준비금은 금리스왑의 재평가에서 발생하는 공정한 평가 움직임을 포함합니다. 예상거래의 현금흐름위험회피수단으로 지정되고 유효한 파생금융상품의 공정가치 변동은 기타포괄손익으로 인식하여 위험회피대상항목의 공정가치 누적변동액에 한하여 현금흐름위험회피적립금 항목으로 적립하고 있습니다. 헤지 시작부터. 유효하지 않은 부분과 관련된 손익은 즉시 당기손익으로 인식합니다. 기타포괄손익으로 인식되어 자본에 누적된 누적금액은 위험회피대상항목이 당기손익으로 인식되는 동일한 기간에 기타포괄손익에서 연결손익계산서로 재분류됩니다.
위의 공시는 그룹과 회사 모두를 위한 것입니다.
기타 예비
기타준비금은 2009년 TMN Group Plc의 역인수 시 발생한 적립금으로 구성되어 있습니다.
외화 환산 준비금
외화환산적립금은 종속기업의 실적을 스털링 이외의 기능통화로 환산할 때 발생하는 환산차이를 포함하고 있습니다. 이러한 외환차이는 해외사업장이 처분되는 기간에 손익계산서에 인식됩니다.
12. 주식기준보상
계획 1 - 새로운 참여자에게 완전히 귀속되고 폐쇄됨
The Group created a share option scheme during the year ended 31 December 2010 and granted the first options under the scheme on 1 January 2011 to certain senior employees. Each option granted converts to one ordinary share on exercise. A participant may exercise their options subject to employment conditions and Adjusted EBITDA targets being met. For these options to be exercised the Group's earnings before interest, taxation, depreciation and amortisation, as adjusted by the Remuneration Committee for significant or one-off occurrences, must exceed certain targets. The fair values of options granted were determined using the Black-Scholes model. The inputs used in the model were:
· 부여일의 주가;
· 행사가격;
· 만기까지의 시간;
· 연간 무위험 이자율; 그리고
· 연간 변동성.
Each of the awards were subject to vesting criteria set by the Remuneration Committee. As disclosed in the 2021 Annual Report and Accounts, the final vesting target of £52m Adjusted EBITDA (excluding the impact of IFRS16) was met in the financial year ending 31 December 2021 and therefore the final tranche of Scheme 1 options vested during 2022. Scheme 1 is now therefore closed.
The total charge recognised for the scheme during the 12 months to 31 December 2023 was £nil (2022: £nil).
The Remuneration Committee approved the vesting of the final tranche of Scheme 1 on 11 August 2022. The awards of the scheme were settled with ordinary shares of the Company. Whilst the majority of participants chose to exercise their options during the year ended 31 December 2022, holders of the remaining 14.3m options (post share reorganisation) chose to defer their exercise, as allowable under the scheme rules. During the year ended 31 December 2023, 9.8m of these options were exercised, resulting in 4.5m deferred options as at 31 December 2023. As a result of these options vesting during the year, £17.3m was transferred from the Group's treasury reserve to retained earnings of which £17.3m is distributable. The weighted average price of the exercised options at the date of exercise was £1.77 per share.
Reconciliation of movement in the number of options is provided below. No new grants were awarded during 2023.
Pre Capital Reorganisation Values | Post Capital Reorganisation Values | |||||
옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | 옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | |
31 12월 2022 | 1 / 14th | 0.0 | 1,994,453 | 1 / 100th | 0.0 | 14,246,083 |
행사 | 1 / 14th | 해당 사항 없음 | (1,369,828) | 1 / 100th | 해당 사항 없음 | (9,784,472) |
31 12월 2023 | 1 / 14th | 0.0 | 624,625 | 1 / 100th | 0.0 | 4,461,611 |
31년 2023월 10일 현재 이월된 옵션은 미결제 상태이며 행사 가능합니다. 나머지 옵션의 최대 기간은 2033년이며 XNUMX년 XNUMX월에 종료됩니다.
계획 2 - 2019 계획
평가에 사용된 가정은 다음과 같습니다.
어워드 트랜치 | 1 상 | 2 상 | 3 상 | 5 상 | 7 상 | 8 상 |
부여 일 | 31/10/19 | 07/05/20 | 25/05/20 | 22/09/20 | 23/03/21 | 31/01/23 |
예상 배당수익률 | 3.06% | 3.06% | 3.06% | 3.06% | 3.06% | 3.57% |
휘발성 | 26.87% | 26.87% | 26.87% | 26.87% | 26.87% | 28.62% |
Initial share price (pre capital reorganisation) | £12.25 | £12.25 | £12.25 | £12.25 | £12.25 | £12.55 |
Initial share price (post capital reorganisation) | £1.72 | £1.72 | £1.72 | £1.72 | £1.72 | £1.76 |
그룹, 100년 1월 2024일까지 £XNUMXm EBITDA 달성 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 |
Fair value (pre capital reorganisation) | £11.79 | £11.79 | £11.79 | £11.79 | £11.79 | £12.07 |
Fair value (post capital reorganisation) | £1.65 | £1.65 | £1.65 | £1.65 | £1.65 | £1.69 |
무위험 이자율 | 3.17% | 3.17% | 3.17% | 3.17% | 3.17% | 3.24% |
예상 몰수율 | 8% | 8% | 8% | 8% | 8% | 7% |
남은 계약기간 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
그룹, 110년 1월 2025일까지 £XNUMXm EBITDA 달성 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 |
Fair value (pre capital reorganisation) | £11.43 | £11.43 | £11.43 | £11.43 | £11.43 | £11.65 |
Fair value (post capital reorganisation) | £1.60 | £1.60 | £1.60 | £1.60 | £1.60 | £1.63 |
무위험 이자율 | 3.24% | 3.24% | 3.24% | 3.24% | 3.24% | 3.32% |
예상 몰수율 | 13% | 13% | 13% | 13% | 13% | 12% |
남은 계약기간 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 | 1.17 |
그룹, 125년 1월 2026일까지 £XNUMXm EBITDA 달성 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 |
Fair value (pre capital reorganisation) | £11.09 | £11.09 | £11.09 | £11.09 | £11.09 | £11.24 |
Fair value (post capital reorganisation) | £1.55 | £1.55 | £1.55 | £1.55 | £1.55 | £1.57 |
무위험 이자율 | 3.20% | 3.20% | 3.20% | 3.20% | 3.20% | 3.12% |
예상 몰수율 | 19% | 19% | 19% | 19% | 19% | 18% |
남은 계약기간 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 | 2.17 |
그룹, 145년 1월 2027일까지 £XNUMXm EBITDA 달성 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 | 25% 조끼 |
Fair value (pre capital reorganisation) | £10.76 | £10.76 | £10.76 | £10.76 | £10.76 | £10.85 |
Fair value (post capital reorganisation) | £1.51 | £1.51 | £1.51 | £1.51 | £1.51 | £1.52 |
무위험 이자율 | 3.24% | 3.24% | 3.24% | 3.24% | 3.24% | 3.21% |
예상 몰수율 | 24% | 24% | 24% | 24% | 24% | 23% |
남은 계약기간 | 3.17 | 3.17 | 3.17 | 3.17 | 3.17 | 3.17 |
Awards 4 and 6 have been fully forfeited. For all options noted within the table above, the post capital reorganisation exercise price per option is £0.0001 (equivalent to 1/100th pence) and the expected dividend yield has been assumed to be paid throughout the performance period. The volatility used within the calculations was determined by calculating the Group's observed historical volatility over a period equal to the time until the end of the assumed maturity date.
The estimated forfeiture rate assumption is based upon Management's expectation of the number of options that will lapse over the vesting period and are reviewed annually. Management believes the current assumptions to be reasonable.
12년 31월 2023일까지 13.6개월 동안 이 제도에 대해 인정된 총 비용은 £2022m입니다(3.3년: £XNUMXm). 제도의 보상은 회사의 보통주로 정산됩니다.
반응식 2의 옵션 수에서 이동 조정이 아래에 제공됩니다.
Pre Capital Reorganisation Values | Post Capital Reorganisation Values | |||||
옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | 옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | |
31 12월 2022 | 1 / 14th | 2.8 | 3,360,000 | 1 / 100th | 2.8 | 24,000,000 |
부여 | 1 / 14th | 해당 사항 없음 | 500,000 | 1 / 100th | 해당 사항 없음 | 3,571,427 |
상실 | 1 / 14th | 해당 사항 없음 | (150,000) | 1 / 100th | 해당 사항 없음 | (1,071,429) |
31 12월 2023 | 1 / 14th | 1.7 | 3,710,000 | 1 / 100th | 1.7 | 26,499,998 |
31년 2023월 XNUMX일 현재 이월된 옵션은 미결제 상태이며 행사 가능합니다.
계획 4 - 2021 계획
평가에 사용된 가정은 다음과 같습니다.
어워드 트랜치 | 1 상 | 2 상 | 3 상 |
부여 일 | 07/03/22 | 31/01/23 | 23/05/23 |
예상 배당수익률 | 3.06% | 3.57% | 3.34% |
휘발성 | 26.87% | 28.62% | 29.40% |
Initial share price (pre capital reorganisation) | £12.25 | £12.55 | £13.10 |
Initial share price (post capital reorganisation) | £1.72 | £1.76 | £1.83 |
그룹, 110년 1월 2025일까지 £XNUMXm EBITDA 달성 | 10% 조끼 | 10% 조끼 | 10% 조끼 |
Fair value (pre capital reorganisation) | £11.43 | £11.65 | £12.35 |
Fair value (post capital reorganisation) | £1.60 | £1.63 | £1.73 |
무위험 이자율 | 3.24% | 3.32% | 4.10% |
예상 몰수율 | 16% | 15% | 13% |
남은 계약기간 | 1.17 | 1.17 | 1.17 |
그룹, 125년 1월 2026일까지 £XNUMXm EBITDA 달성 | 20% 조끼 | 20% 조끼 | 20% 조끼 |
Fair value (pre capital reorganisation) | £11.09 | £11.24 | £11.94 |
Fair value (post capital reorganisation) | £1.55 | £1.57 | £1.67 |
무위험 이자율 | 3.20% | 3.12% | 4.02% |
예상 몰수율 | 22% | 21% | 19% |
남은 계약기간 | 2.17 | 2.17 | 2.17 |
그룹, 145년 1월 2027일까지 £XNUMXm EBITDA 달성 | 70% 조끼 | 70% 조끼 | 70% 조끼 |
Fair value (pre capital reorganisation) | £10.76 | £10.85 | £11.55 |
Fair value (post capital reorganisation) | £1.51 | £1.52 | £1.62 |
무위험 이자율 | 3.24% | 3.21% | 3.97% |
예상 몰수율 | 28% | 27% | 25% |
남은 계약기간 | 3.17 | 3.17 | 3.17 |
For all options noted within the table above, the post capital reorganisation exercise price per option is £0.0001 (equivalent to 1/100th pence) and the expected dividend yield has been assumed to be paid throughout the performance period. The volatility used within the calculations was determined by calculating the Group's observed historical volatility over a period equal to the time until the end of the assumed maturity date.
예상 몰수율 가정은 가득 기간 동안 소멸되고 매년 검토되는 옵션의 수에 대한 경영진의 예상을 기반으로 합니다. 경영진은 현재 가정이 합리적이라고 생각합니다.
12년 31월 2023일까지 5.8개월 동안 이 제도에 대해 인정된 총 비용은 £2022m입니다(0.8년: £XNUMXm). 제도의 보상은 회사의 보통주로 정산됩니다.
반응식 4의 옵션 수에서 이동 조정이 아래에 제공됩니다.
Pre Capital Reorganisation Values | Post Capital Reorganisation Values | |||||
옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | 옵션행사가격 (펜스) | 남은 수명 (연령) | 수 옵션 | |
31 12월 2022 | 1 / 14th | 3.9 | 1,716,000 | 1 / 100th | 3.9 | 12,257,143 |
부여 | 1 / 14th | 해당 사항 없음 | 1,446,000 | 1 / 100th | 해당 사항 없음 | 10,328,477 |
상실 | 1 / 14th | 해당 사항 없음 | (412,000) | 1 / 100th | 해당 사항 없음 | (2,942,857) |
31 12월 2023 | 1 / 14th | 2.8 | 2,750,000 | 1 / 100th | 2.8 | 19,642,763 |
31년 2023월 XNUMX일 현재 이월된 옵션은 미결제 상태이며 행사 가능합니다.
13. 우발부채
The Group has a contingent liability in relation to professional fees incurred which become payable upon completion of the investment agreement. The total potential fee payable amounts to £6.6m.
In addition, taxation charges are expected to crystallise within the Group as a result of entering into the investment agreement, based on the steps required to re-organise the Healthcare business into its own corporate perimeter. The ultimate cash tax payable will be based on the specific facts and circumstances, including the relevant value of the Healthcare business attributable to the jurisdictions in which it operates and the relevant tax laws and regulations of each territory, however, the current charge is estimated to total £20.7m.
There were no contingent liabilities as at 31 December 2022.
14. 인수
The Group did not undertake any acquisitions during the year ended 31 December 2023, however a contingent consideration payment of £0.2m in relation to the MBI acquisition (acquired during the year ended 31 December 2022) was made.
15. 특수관계자 거래
Mike Danson, GlobalData's Chief Executive, owned 59.1% of the Company's ordinary shares as at 31 December 2023 and 57.8% as at 4 March 2024 and is therefore the Company's ultimate controlling party. Mike Danson owns a number of other businesses, a small number of which interact with GlobalData Plc.
이사회는 관련 당사자 거래가 잘 통제되고 관리되도록 추가 통제 프레임워크를 마련했습니다. 특수관계자 거래는 이사회 소위원회에서 감독합니다. 비상임 이사 4명으로 구성되고 Murray Legg가 의장을 맡은 내부 거래 위원회는 다음을 위해 모입니다.
o 모든 관련 당사자 거래를 감독합니다.
o 거래가 GlobalData와 더 넓은 이해 관계자에게 최선의 이익이 되도록 보장합니다. 그리고
o 모든 거래가 독립적으로 기록되고 공개되도록 합니다.
As previously noted, it is the intention of the Board and Management to reduce and eventually eliminate related party transactions and wind down the service agreements that are currently in place. During 2023 we have continued the progress made in 2021 and 2022 and now expect to have eliminated all legacy relationships with related parties by 31 December 2024.
당기 중 연결실체가 체결한 특수관계자 거래는 다음과 같습니다.
숙소 안내
GlobalData Plc sub-let office space to other companies owned by Mike Danson, but this materially ceased in 2021 with the exception of one property (the related party tenant exited as at 31 December 2022 and therefore no related party property transactions happened in 2023). The total sub-lease income for the year ended 31 December 2023 was £nil (2022: £0.1m). During the year ended 31 December 2023, the Group utilised a private yacht (owned by Mike Danson) to host a commercial event. The Group paid disbursements for food, drinks and staff wages whilst hosting the event, which amounted to £34,000 (2022: £nil).
기업 지원 서비스
In 2023 net corporate support charges of £0.1m were charged from NS Media Group Limited ("NSMGL") and net corporate support charges of £0.1m were charged to Estel Property Investments No.3 Limited, both companies are related parties by virtue of common ownership (2022: £0.6m charge from NSMGL). The corporate support charges in 2023 consist of a share of the India management team cost which have been recharged on a consistent basis to other corporate support charges in previous years and are determined by headcount. Additionally included in the charges are shared software development and recharged salary costs. In 2022 the corporate support charges principally consisted of shared IT support and software development, the contract for which ended during 2022.
Progressive Trade Media Limited에 대한 대출
The previous outstanding loan was fully repaid on 31 January 2022 and generated interest income in 2023 of £nil (2022: £5,000). Interest was charged throughout the term of the loan at a rate of 2.25% above LIBOR. The loan was specifically entered into in relation to the divestment of non-core print and advertising businesses in 2016 and no further loan relationships are expected.
IP 공유 조항이 포함된 수익 계약
The Group entered into a five-year data services agreement with NSMGL in June 2020. The agreed suite of data services provided to NSMGL was contracted on terms equivalent to those that prevail in arm's length transactions. The Group mutually agreed with NSMGL to terminate this agreement on 1 July 2022 in order to reduce the amount of related party transactions as well as a different strategic direction in NSMGL. The total revenue generated from this contract during 2023 was £nil (2022: £0.4m) and the net contribution generated was £nil (2022: £0.2m). The cancellation was in accordance with the contracted terms.
NSMGL은 일부 GlobalData 제품의 판매 대리점 역할도 했습니다. 이 거래에서 그들은 £0.2m(2022년: £0.2m)의 에이전트 수수료를 부과했습니다.
자선 기부
During the year the Group paid donations of £0.04m (2022: £0.1m) to charities in India which were funded by a related party entity, The Danson Foundation (charity reference 1121928). This was a pass-through transaction, with the Group facilitating payment to charities in India.
Balances outstanding
31년 2023월 XNUMX일 현재 NSMGL에서 받을 수 있는 총 잔액은 £XNUMX입니다. 이 미수금과 관련하여 특정 신용 손실 조항이 없으며 해당 기간 동안 불량 또는 의심스러운 부채와 관련하여 인식된 총 비용은 £XNUMX입니다.
The Group has taken advantage of the exemptions contained within IAS24: Related Party Disclosures from the requirement to disclose transactions between Group companies as these have been eliminated on consolidation. The amounts outstanding for other related parties were £nil (2022: £nil). There were no other balances owing to or from related parties.
이사 및 주요 경영진
The remuneration of Directors is disclosed within the Directors' Remuneration Report within the Group's Annual Report and Accounts for the year ended 31 December 2023.
RNS는 귀하의 IP 주소를 사용하여 약관 준수 여부를 확인하고, 귀하가 이 커뮤니케이션에 포함된 정보를 사용하는 방식을 분석하고, 그러한 분석을 익명으로 다른 사람과 상용 서비스의 일부로 공유할 수 있습니다. RNS와 런던 증권 거래소가 귀하가 제공한 개인 데이터를 사용하는 방법에 대한 자세한 내용은 개인 정보 보호 정책을 참조하십시오.